Development of a Forward/Adjoint Hybrid Monte Carlo Absorbed Dose Calculational Method for Use in Radiation Therapy by Tamimi, Mat M.
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
Doctoral Dissertations Graduate School
12-2014
Development of a Forward/Adjoint Hybrid Monte
Carlo Absorbed Dose Calculational Method for
Use in Radiation Therapy
Mat M. Tamimi
University of Tennessee - Knoxville, mtamimi@vols.utk.edu
This Dissertation is brought to you for free and open access by the Graduate School at Trace: Tennessee Research and Creative Exchange. It has been
accepted for inclusion in Doctoral Dissertations by an authorized administrator of Trace: Tennessee Research and Creative Exchange. For more
information, please contact trace@utk.edu.
Recommended Citation
Tamimi, Mat M., "Development of a Forward/Adjoint Hybrid Monte Carlo Absorbed Dose Calculational Method for Use in
Radiation Therapy. " PhD diss., University of Tennessee, 2014.
https://trace.tennessee.edu/utk_graddiss/3172
To the Graduate Council:
I am submitting herewith a dissertation written by Mat M. Tamimi entitled "Development of a Forward/
Adjoint Hybrid Monte Carlo Absorbed Dose Calculational Method for Use in Radiation Therapy." I have
examined the final electronic copy of this dissertation for form and content and recommend that it be
accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in
Nuclear Engineering.
Ronald E. Pevey, Major Professor
We have read this dissertation and recommend its acceptance:
Laurence F. Miller, Lawrence W. Townsend, Aly Fathy
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)
  
 
 
Development of a Forward/Adjoint Hybrid Monte 
Carlo Absorbed Dose Calculational Method for Use in 
Radiation Therapy 
 
 
 
 
 
 
A Dissertation Presented for the 
Doctor of Philosophy 
Degree 
The University of Tennessee, Knoxville 
 
 
 
 
 
 
Mat M. Tamimi 
December 2014 
  
ii 
 
 
 
 
 
 
 
 
Copyright © 2014 by Mat M. Tamimi 
All rights reserved 
 
 
 
  
iii 
 
DEDICATION 
This dissertation is dedicated to 
The two people that brought me to this life, my parents Abdel Jawad and Khawla; 
The anchors of my being, my brothers and sisters Aminah, Imad, Rula, Mobeen and 
Tasneem; 
The love of my life, my wife Cristina; 
The light in my life, my girls Nancy, Samira and Ayat; 
and the hope for my future my grandchildren, my boys Nabeel and Yasser. 
  
iv 
 
ACKNOWLEDGEMENTS 
I would like to thank Dr. Ronald Pevey, my faculty advisor, for guiding me through this 
project and being extremely patient with my progress.  I would like to thank my committee 
members, Dr. Laurence F. Miller, Dr. Lawrence Townsend, for taking the time to review my 
paper and attend my presentation, and Dr. Aly Fathy for his encouragement and continual 
support.  And I would like to thank the rest of the Department of Nuclear Engineering at the 
University of Tennessee for allowing me the opportunity to complete my project.  I would like 
also to thank my colleagues and long term friends Mark Wyatt, Robert Drinnon, Ibrahim Attieh 
and Robbie Hakeem for all valuable discussions and support throughout all phases of the project.  
I also want to thank my close friends Ramadan Damiri, Mohamad Nofal and Mohamad Al 
Shanquiti for their continual encouragement and support all the time.  I also would like to thank 
my best buddy and close relative Nihad Abdel Nabi Al Natcha and his business “Electronic 
Tech” for the generosity and support dealing with all the computer and technical issues.  Finally, 
I would like to thank my parents, brothers and sisters, wife and the girls for their patience, 
encouragement, their help and support throughout this endeavor. 
 
  
v 
 
ABSTRACT 
A successful radiation therapy treatment aims at conforming (i.e., concentrating) radiation 
dose to the entire tumor volume (i.e., diseased area) while avoiding surrounding normal tissue 
(i.e., healthy non-diseased areas).  This objective is achieved clinically by finding a set of 
radiation beam parameters that successfully deliver the desired dose distribution. 
In this project, a hybrid forward/adjoint Monte Carlo based absorbed dose computation 
method is developed and tested, aimed at eventual implementation in a radiation therapy external 
beam treatment planning system to predict the absorbed dose produced by a medical linear 
accelerator.  This absorbed dose calculational engine was designed to be: 
1. Efficient. This is achieved by incorporating several Monte Carlo techniques used in the 
Nuclear Engineering field for deep penetration and reactor analysis problem. 
2. Flexible. This is achieved by using a Cartesian grid and a voxelized material map. 
Currently most of the absorbed dose calculation algorithms in radiotherapy are 3-D based 
predictive models.  The use of such algorithms results in treatment planning quality that depends 
tremendously on the planner’s experience and knowledge base.  This dependence, along with 
inaccuracy in predicting absorbed dose due to the assumptions and simplifications used in these 
algorithms, can result in a predicted absorbed dose that under- or over-predicts the delivered 
dose. 
As an alternative, forward and adjoint Monte Carlo absorbed dose computation methods have 
been used and validated by several authors (Difilippo, 1998; Goldstein & Regev, 1999; Jeraj & 
Keall, 1999). However, in the “pure” forward or adjoint methods, each change in the radiation 
beam parameters requires its own time-consuming 3D calculation; for the hybrid technique 
developed in this research, a single 3D calculation for each desired dose region (tumor or healthy 
organ) is all that is required. 
This project also improves the Monte Carlo methodology by incorporating the use of 
voxelized fictitious scattering and surface forward/adjoint coupling.  The accuracy is 
demonstrated through comparison with forward and adjoint MCNP calculations of a simple 
beam/patient sample problem.  
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  Chapter 1
Background and Introduction 
1.1. History of Radiation therapy 
The possibilities for therapeutic use of radiation were immediately recognized soon after the 
discovery of x-rays in 1895 (Dowsett, Kenny, & Johnston, 1998).  Clinicians started to use x-
rays to treat cancers while researchers investigated different x-ray production and delivery 
methods.  Soon after consequences of radiation misuse were observed, the medical community 
realized the need to control treatment outcome and the “Radiation Therapy” field was born. 
Radiation therapy is the branch of medicine that deals with the use of radiation as a method to 
treat cancer.  Due to the large amount of radiation and radiobiology research, a lot of 
accomplishments in radiation therapy have been realized since that time. 
Figure 1-1 summarizes in a pictorial format these historical accomplishments 
chronologically, beginning with the discovery of x-rays by Wilhelm Conrad Roentgen in 1895 
and continuing to the most recent advancements in medical linear accelerator design and imaging 
methods.  The field is constantly advancing and evolving due to the continual need to have better 
control on treatment outcomes (Hall, 1988). 
Radiotherapy is the treatment of cancer by means of ionizing radiation.  The purpose of 
radiotherapy is to eradicate the tumor and spare the surrounding normal tissues as much as 
possible (Colvett, 2006).  To achieve this objective, clinicians need to have both x-ray delivery 
systems (e.g., medical linear accelerator (Linac)) and absorbed dose prediction systems (e.g., 
treatment planning systems (TPS)).  The Linac should be able to produce several types of 
radiation (e.g., x-ray or charged particle beams (electrons)) and employ several delivery methods 
(e.g., static versus dynamic methods).  At the same time, the TPS should have the ability to 
account for the patient anatomy to  predict delivered dose with high accuracy (Metcalfe, Kron, & 
Hoban, 1997). 
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Figure 1-1 Time line for radiation therapy advancements 
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1.2. Radiobiology background 
It is the aim of radiotherapy to minimize the damage to healthy tissue while administering a 
killing dose to the tumor.  The amount of dose required to achieve a particular level of cell 
killing is extremely variable because cells have different radiosensitivites (Williams & Thwaites, 
2000).  The killing of individual cells using radiation is statistical in nature, depending on the 
occurrence of individual ionizing events.  However, when the effect of radiation on a large 
collection of cells is considered, whether it is a tumor mass or an organ, the effect is largely 
deterministic; there is a dose threshold below which no clinical effect will be observed and a 
dose above which the effect will be observed in every individual. 
The biological response of a cell to the amount of dose received can be illustrated in dose-
response curves, examples of which are given in the Figure 1-2.  As delivered dose increases, 
more cells are destroyed; these curves show that a sigmoidal relationship exists between 
radiation dose and the probability of achieving tumor control.  This principle also applies to 
normal tissue and cells.  As a result, the probability of normal tissue complications (NTCP) and 
tumor control (TCP) are similar.  The relationship between the NTCP and the TCP is known as 
the therapeutic ratio, also illustrated in Figure 1-2. 
 
Figure 1-2 Therapeutic ratio concept from cell response curve 
The probability of a favorable outcome is good when the TCP curve is to the left of the 
NTCP curve.  An increase in delivery and computation accuracy is required when the TCP and 
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NTCP curves are very close to each other, requiring very accurate delivery methods.  When the 
TCP curve is to the right of the NTCP curve, combined modality approaches are needed (e.g., 
chemo-radiation or interstitial/intracavitary implants).  The tumors treated successfully by 
radiotherapy are those in which the tumor curve lies to the left of the curve for the limiting 
normal tissue.  For those types of tumors, the dose required to achieve a high probability of 
complete regression of the tumor is lower than the dose that produces a significant number of 
complications in normal tissue.  In these situations, treatment plans are desired to assure that the 
high dose region conforms to the shape of the target volume as much as possible—sparing 
normal tissue—by applying beams with conformal shapes from several directions (Williams & 
Thwaites, 2000). 
The next few sections will review the evolution of both radiation therapy techniques, 
treatment planning techniques, and the corresponding absorbed dose prediction methods. 
1.3. Radiation therapy treatment techniques 
The control of delivered absorbed dose is achieved using radiation therapy techniques, which 
have evolved over time.  Figure 1-3 summarizes this development.  
Initial treatment techniques were simple to plan and to deliver due to limitations in first 
generation medical linear accelerators.  With the advancements in computer technology, 
improved designs and features of the medical linear accelerators led to developments of newer 
treatment techniques (Thwaites & Tuohy, 2006). 
 
Figure 1-3 Evolution of radiotherapy techniques (Bentel, Nelson, & Noell, 1982) 
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The three-dimensional conformal radiotherapy (3DCRT) was introduced in the early 1980’s 
(Colvett, 2006).  Initially this treatment method used shielding blocks made manually from low 
melting point metal (e.g., Cerrobend).  With the most recent advancement in computer-controlled 
Linacs, manufacturers have developed mechanical blocking systems referred to as multi-leaf 
collimators (MLCs).  These devices replace the need to fabricate shielding blocks and give 
planners the ability to vary beam intensity and shape across a radiation field; this has given birth 
to the latest treatment technique, intensity modulated radiation therapy (IMRT).  Furthermore, 
the recent development of digital imaging receptors have led to the introduction of the image 
guided radiation therapy (IGRT) technique by adding on board imaging (OBI) systems to the 
accelerators (see Figure 1-4).  Clinicians are able to localize tumor position with more precision 
using this technique, by imaging the patient before the initiation of treatment and by monitoring 
the treatment progress through imaging during the treatment (Colvett, 2006; Thwaites & Tuohy, 
2006). 
 
Figure 1-4 Medical linear accelerator equipped with MLC and OBI 
1.4. Treatment planning techniques 
1.4.1. 3DCRT process versus IMRT process 
Using the 3DCRT planning methods requires the planner to compute a dose distribution and 
evaluate the resulting volumetric dose using a Dose Volume Histogram (DVH) (Armstrong et 
al., 1993) to see if the treatment objectives are achieved.  On the other hand, IMRT uses a 
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computerized algorithm that searches for the solution and evaluates the results until a suitable 
solution is found.  
The optimization parameters and structure “penalty weights” are the primary variables used 
to control the IMRT search for optimal dose distributions, as opposed to the beam weight or 
shape optimization in the 3DCRT treatment planning search.  Specification of the optimization 
parameters and beam placement requires detailed knowledge of the dose calculation algorithms 
and anatomical features of the patient, such as the proximity of the normal tissue to the target. 
As a result, the combination of beams, optimization parameters, and beam shaping structures 
needed to achieve the best plan are planning system and patient specific.  Planners must develop 
an intuition as to how these factors affect distributions, so the plan can be optimized. 
1.4.2. Manual optimization 
The processes of creating IMRT or 3DCRT treatment plans are quite similar, but the bases of 
the plan designs are significantly different.  The conventional 3DCRT treatment planning is 
forward based and optimization is done manually. 
The process starts when the treatment planner chooses initial beam parameters (i.e., number 
of beams, beam energy, weighting, direction, and beam modifying devices such as blocks and 
wedges).  The computer then calculates the resulting dose distribution, which is evaluated by the 
planner.  At this point, the planner can chose to accept or reject the plan based on the physician’s 
defined criterion.  If the distribution is not satisfactory, the planner designs another plan by 
adjusting the various beam parameters.  The new dose distribution is computed and evaluated 
and the process is repeated until the planner arrives at a satisfactory absorbed dose distribution.  
Therefore in conventional 3DCRT treatment planning the planner arrives at the optimized dose 
distribution without having to explicitly define the optimum or desired dose distribution. 
1.4.3. Computer-aided optimization 
Researchers have attempted to improve on the tedious trial and error nature of the manual 
process by automating it using computer-driven parameter optimization. 
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1.4.3.1. 3DCRT process planning 
In one early method the “beam's eye view” was used for accurate delineation of treatment 
volumes to avoid real or dosimetric geographic misses.  This was especially useful for oblique 
fields because it “facilitated the design of accurate customized blocking and avoided inadvertent 
blocking of the tumor or unnecessary irradiation of normal tissues” (Vijayakumar et al., 1991).  
Another method proposed by Soderstrom and Brahme used two different measures for the 
selection of advantageous beam directions: “lowest entropy” and “low frequency part of the 
Fourier transform” of the optimal beam profiles (Soderstrom & Brahme, 1992).  Langer and 
Leong described a method for “formulating and solving this optimization problem as a 
combinatorial linear program” (Langer & Leong, 1987). 
A method by Mageras and Mohan utilizes the simulated annealing approach to optimize 
radiation treatment plans; in this method, a set of beam weights are iteratively adjusted so as to 
minimize a cost function.  This method was motivated by its potential for finding the global or 
near‐global minimum among multiple minima. This method was found to be slow, requiring 
several tens of thousands of iterations to optimize 50 to 100 variables.” (Mageras & Mohan, 
1993)  
1.4.3.2. IMRT process planning 
Treatment goals are best achieved using IMRT.  The IMRT process is made of three integral 
parts—an inverse treatment planning process, plan delivery design (static or dynamic delivery), 
and quality assurance of the produced plans. 
In the inverse planning step, the planner aims at finding the radiation beam parameters that 
will produce the desired absorbed dose distribution, as shown in Figure 1-5.  The IMRT planner 
accomplishes this task by searching iteratively for a set of beam parameters for an optimal 
fluence that will deliver the desired dose distribution.  First, the planner evaluates and stops the 
optimization when the optimized plan produces dose distribution that meets criterion defined at 
the start of optimization.  Second, the accepted optimal dose distribution is converted to a 
machine deliverable treatment plan by producing a multi leaf collimator (MLC) motion sequence 
that will produce this dose distribution.  Lastly, the treatment plan is verified to assure that the 
produced leaf motion sequence will produce the optimal calculated dose distribution in the 
patient.   
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Figure 1-5 IMRT solution for tumor dose 
During the IMRT optimization process, the planner defines the desired absorbed doses for 
the following structure volumes as described in ICRU reports 29, 50 & 71 (Morgan-Fletcher, 
2001; Units & Measurements, 1978): 
1. CTV (clinical target volume).  This normally is the gross tumor volume and 
subclinical extensions. 
2. PTV (planning target volume).  This is the CTV plus added margins to account 
for variations in tissue positions, sizes, and shapes, as well as for variations in 
patient position and beam geometries, both intrafractionally (i.e., during the 
treatment) and interfractionally (from one treatment to another). 
3. OAR (organs at risk).  Radiosensitive normal tissues, whose radiation sensitivity 
may significantly affect treatment planning (i.e., spinal cord, heart, parotids, etc.).  
Dose-volume (DVH) constraints are determined by the planner through the 
definition of maximum allowable doses for these organs, along with a set of 
penalty weights to indicate the relative importance of the organ. 
1.5. Treatment plan delivery design 
Once an IMRT plan is designed, it can be delivered via several methods: 
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1. Physical compensators (Purdy, 1997).  These are used to modify the dose 
distribution to conform to irregular target shapes due to missing tissue or irregular 
patient contours; the fabrication is time consuming and their use is cumbersome.  
A picture of an actual compensator is shown in Figure 1-6. 
 
Figure 1-6 IMRT Physical compensator delivery solution 
 
2. Computer-controlled slit and multi-leaf collimators (MLCs) (Carol, 1994) 
sequences as shown in Figure 1-7.  
 
Figure 1-7 IMRT MLC delivery solution   
 
These have made the delivery of intensity-modulated fields more practical by allowing 
delivery of the IMRT plan using either multiple static fields or one dynamic field with dynamic 
multi-leaf collimator (DMLC) as described in (Spirou & Chui, 1994).  The static method is 
commonly referred to as “Step-and-Shoot” method while the dynamic method is referred to as 
the “Sliding window” method.  Each delivery method has its advantages and limitations.  In the 
literature there exist some studies comparing delivery methods (Chui, Chan, Yorke, Spirou, & 
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Ling, 2001), but there are really no available data that permit a true head-to-head comparison 
between the currently available various IMRT delivery techniques. 
1.6. Absorbed dose calculation techniques 
Accurate knowledge of delivered absorbed dose is critical for predicting the clinical 
outcomes of the prescribed radiation treatments.  This goal dictates dose assessment tools that 
are able to predict delivered dose with high precision and accuracy. 
1.6.1. Evolution of absorbed dose calculations techniques 
In the early algorithms, absorbed dose in the patient was estimated using simplifications such 
as assuming that the patient was totally composed of water, ignoring all internal organs and only 
using the external patient contour (Nikos  Papanikolaou et al., 2004).  These simplifications 
introduced errors when computing the final absorbed dose distribution, due to the fact that 
absorbed dose distributions are highly dependent on the differing material densities and atomic 
compositions in the human body. 
Advances in imaging led to the development of CT-based dose corrections methods.  A full 
map of the patient’s internal anatomy can be constructed from electron density map generated by 
CT’s (Nath et al., 1994).  This electron density map is converted into a material map through a 
conversion process allowing planners to predict dose distribution that is close to the actual dose 
distribution for the internal anatomy (Sontag & Cunningham, 1978).  The initial calculational 
methods employing CTs were one dimensional correction methods while the most recent 
methods are three dimensional and aim at achieving better absorbed dose prediction accuracy 
(Nikos  Papanikolaou et al., 2004).   Table 1-1 summarizes these calculation methods. 
Table 1-1 Absorbed dose calculations method that uses CT data 
Absorbed dose calculation methods that uses CT data 
1-D 1. Ratio of tissue Air Ratio factors (rTAR) 
2-D 
1. Equivalent Tissue Air Ratio factors (eTAR). 
2. Fast Fourier Transform method (FFT). 
3-D 
1. Differential scatter air ratio (DSAR). 
2. Delta volume. 
3. Dose spread array. 
4. Differential pencil beam. 
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These advances led to the development of the convolution superposition techniques.  The 
convolution superposition techniques are predictive models that simulate particle transport and 
energy deposition in human tissues.  The models use a database of deposition kernels calculated 
using Monte Carlo techniques and mathematical expression to predict the absorbed dose 
distribution.  Some of the most common algorithms that use the superposition convolution 
techniques are the Point Kernel model (Pencil Beam algorithm), the direct summation method, 
and the collapsed cone method (Ahnesjö, 1999 #92, Papanikolaou, 2004 #68).  The difference 
between these models is the way they deal with the changes in the primary fluence and changes 
in the spread of deposited energy when computing absorbed dose distributions. 
In general, treatment planning systems algorithms are divided into two major types: 
1. Lookup-based algorithms.  These algorithms provide point doses estimates in 
patients based on conversion factors of the doses derived from a look-up table. 
2. Model-based algorithms.  The collected clinical data are fitted into mathematical 
physical models, which are used to predict the dose distribution in the entire 
volume in question based on a superposition convolution dose algorithm. 
1.6.2. Shortcomings of the predictive methods 
Existing clinical practice favors model-based algorithms because they offer fast computation 
speed.  In general, there are two methods to calculate absorbed dose: simplified and detailed. The 
simplified method is called the analytical (deterministic) method, which calculates absorbed dose 
based on several assumptions (e.g., ignoring patient internal anatomy and assuming the patient is 
homogenous medium).  The detailed methods are Monte Carlo simulations of the actual physical 
phenomenon, with the computed absorbed dose based on simulated particles transported in a 
geometrically accurate model of a phantom or patient (Metcalfe et al., 1997). 
When computing absorbed dose using a predictive model, dose from primary photons is 
explicitly calculated and simplifications (e.g., tissue heterogeneities) are applied to compute the 
dose deposited by scattered radiation.  This approach is not desirable because it leads to under- 
or over-estimating of the predicted absorbed dose; its accuracy needs to be increased in order for 
us to be able to use these algorithms clinically.  Currently, this is accomplished by collecting an 
extensive set of beam data for every possible beam combination.  As a result, an accurate beam 
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model is created and used in the treatment planning system to compute absorbed dose (Nikos 
Papanikolaou & Klein, 2008). 
1.7. Monte Carlo: The best dose calculation method 
The Monte Carlo simulation methods are very accurate and are considered to be the gold 
standard for dose calculation (Rogers, 2006) in medical physics, since accurate knowledge of the 
delivered absorbed dose is crucial in predicting the clinical outcomes of the prescribed 
treatments.  Currently, any deterministic method developed is benchmarked against Monte Carlo 
simulations.  
The primary pitfalls of the direct use of Monte Carlo in treatment planning are the large 
amount of computer time and data storage required and the extreme effort needed to validate the 
results. The best solution is to improve the efficiency of Monte Carlo through improved 
methodology development, as represented by this project. 
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  Chapter 2
Monte Carlo method background 
2.1. Monte Carlo history 
Use of Monte Carlo (MC) methods has increased in radiation therapy planning in recent 
years due to the large gains in computer power per unit cost and the availability of many 
powerful software tools.  The Monte Carlo methods use statistical sampling for performing 
numerical integrations and system simulations.  The MC method in its form today was first 
developed and named at the end of the Second World War.  The main motivation behind 
developing MC techniques was radiation transport for nuclear weapons design; Stanislaw Ulam 
and John von Neumann saw an opportunity to develop this new statistical sampling application 
because of the availability of ENIAC, the first electronic computer (Chetty et al., 2007). 
The development of MC techniques has continued to parallel the exponential increase in the 
power of digital computers, as they became widely available to universities, research 
laboratories, and other large institutions in the 1950s and 1960s (Chetty et al., 2007).  The 
attention in the medical physics field was directed to Monte Carlo methods as the need for better 
and more accurate dose calculation algorithms increased. 
2.2. Monte Carlo as a radiation transport tool and absorbed dose calculator 
Monte Carlo methods simulate radiation particle histories as random walks.  In its simplest 
form, each simulated particle is followed from its inception until its death, with decisions at each 
particle event made based on basic physics laws to mimic actual radiation interactions in media; 
the resulting measurable outcomes (e.g., dose in desired regions) are collected from the sampled 
histories and statistically analyzed to estimate the expected outcomes from real particles. 
This technique for calculating dose in patients is favored due to the simplicity of the 
underlying physical basis when compared to the analytic (deterministic) algorithms.  In addition, 
this method only requires knowledge of the relative probability and outcomes of various physical 
interactions that have been understood since the mid-20th century; even though the interactions 
may be complex to simulate in detail, the basic ideas of each interaction are well understood.  
Hence, the overall process is easy to comprehend and implement in a computer code.  
Furthermore, dose computation is straight forward and can be performed during the simulation 
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without complex approximations or models of dose deposition.  This manner of computing doses 
from first principles makes it superior to conventional dose calculation methods. 
2.3. Modes of Monte Carlo radiation transport 
We can simulate a radiation particle’s random walk using Monte Carlo methods from an 
actual source to all regions of interest in a patient and then compute the expected dose to these 
regions.  This mode of calculation is referred to as the forward mode.  Alternatively, we can 
think of radiation particles starting in a region of interest and traveling backwards in time and 
space towards a source.  This mode of transport is referred to as the adjoint mode.  Or, finally, 
we can devise a hybrid mixture of the forward and adjoint calculations which combines the 
advantages of each.  The following subsections provide a brief description of each of these 
approaches. 
2.3.1. Forward Monte Carlo radiation transport 
In forward Monte Carlo radiation transport, photons interactions with matter are described by 
the forward Boltzmann transport equation (Bell & Glasstone, 1970).  The transport process starts 
with the initial position, direction, and energy determined from the particular statistical 
distributions characterizing the photon beam source.  The photons undergo interactions, such as 
photoelectric effect, Compton scattering and pair production, as they travel through the system.  
By keeping track of interaction rates in regions of interest, we can estimate average fluxes in 
those regions.  Other flux-based quantities can be estimated by multiplying flux contributions by 
pre-calculated conversion factors (e.g., for absorbed dose, a flux-to dose response function 
(ANSI/ANS-6.1.1, 1977)).  In the field of medical physics, forward Monte Carlo radiation 
transport is used to compute the dose rate in all voxels inside a region of interest, for a given set 
of source parameters and these voxel dose rates are converted into an expected average dose in 
the region.  This dose rate is usually normalized to the dose delivered per source particle.  For 
this project the Voxel8 computer code was developed to solve the forward problem; its detailed 
algorithm and description is presented in Chapter 5. 
It is often stated in the medical physics literature that the forward Monte Carlo dose 
calculations are too time consuming for regular clinical use.  The primary reason for this is that 
separate long-running forward Monte Carlo calculations through the 3D patient geometry are 
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required for each of the many sets of radiation parameters considered by the planner; this makes 
each step of the planning process take an inordinate amount of time to evaluate.  
2.3.2. Adjoint Monte Carlo radiation transport 
The adjoint transport equation (Bell & Glasstone, 1970) describes the transport of adjoint 
photons  emerging from a region of interest and travelling toward the source.  The adjoint 
photons are transported in a fashion similar to the forward photons, with the following 
exceptions: 
• Instead of starting in the source beam (with initial position, direction, and space 
chosen according to the characteristic beam distributions), the adjoint particles start in 
the region of interest (particular to a calculation) uniformly, isotropic in direction, and 
with an energy distribution corresponding to the groupwise flux-to-dose conversion 
factors. 
• Instead of starting with a particle weight that is the sum of the groupwise sources (i.e., 
total source strength), the adjoint particles begin with a weight equal to the sum of the 
groupwise flux-to-dose conversion factors. 
• When a scattering event occurs, the group-to-group scattering matrix is inverted (i.e., 
adjointed) so that particles scatter from the original group to a final group according 
to the physical cross section appropriate to scattering the other way.  For example, the 
normal scattering cross section from group 1 to group 3 is used to find the probability 
of scattering from group 3 to group 1. 
• To properly normalize the previous energy group reversal, the traditional “absorption 
weighting” multiplicative weight correction of: 
 ∑ Σ→	
Σ 
ΣΣ 
 
used in the forward mode after each scatter is replaced in adjoint calculations with:  
 ∑ Σ→	
Σ  
16 
 
(With the superscripts reversed like this, there is no physical interpretation of the 
numerator.) 
The calculated adjoint flux at a particular point, direction, and energy can be interpreted as 
the expected contribution of an emerging photon with those parameters to the dose at the ROI 
used as the adjoint source.  As a result, the total dose to the ROI can be calculated rapidly by 
multiplying the source (as a function of space, energy, and direction) times the adjoint flux and 
integrating over all independent variables (convolution of the external source function with the 
adjoint flux).  Therefore, for a known and unchanging set of source parameters, a single adjoint 
calculation for each region of interest could be calculated; specifically for each unique patient 
geometry.  For this project the Pixel8 computer code was developed to solve the adjoint problem; 
its detailed algorithm and description is presented in Chapter 5. 
2.3.3. Hybrid forward/adjoint Monte Carlo radiation transport 
Direct use of the adjoint method would require that the calculation geometry include the 
location of the source point, which for our application is outside the patient.  Therefore, 
efficiencies can be gained by performing an adjoint calculation from the region of interest to the 
patient surface, a forward calculation from the source to the patient surface, and combining the 
results. 
The hybrid forward/adjoint Monte Carlo transport method restricts the adjoint calculation to 
the patient geometry and computes the surface adjoint flux by particle type, location, direction 
and energy.  The resulting surface fluxes serve as surface sensitivity functions, equal to the dose 
contribution that would occur to the region of interest (i.e., region that served as the adjoint 
source) of a forward particle impinging on the surface at the indicated surface position, direction, 
and energy group.  
The advantage of this hybrid approach is that the long-running adjoint calculation is 
independent of the source beam parameters, so can be precalculated for the patient’s regions of 
interest as a preliminary step of the treatment planning process.  Then, each source beam 
arrangement that the planner wants to consider can be evaluated very quickly with a fast-running 
forward transport of the beam to the patient surface - often ignoring air attenuation - using the 
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precalculated adjoint surface fluxes as multiplicative flux-to-dose conversions factors to 
determine the contribution to the dose in the region of interest. 
The basic approach was first developed for general radiation shielding analysis in the “Monte 
Carlo Adjoint Shield” (MASH) code system at the University of Tennessee (in collaboration 
with the Oak Ridge National Laboratory) as part of J.O. Johnson’s PhD dissertation (Johnson, 
1992).  MASH performs the forward phase of the calculation with a discrete ordinates code that 
“determines the fluence on a coupling surface surrounding the shielding geometry due to an 
external neutron/gamma-ray source.  The Monte Carlo [adjoint] calculation determines the 
effectiveness of the fluence at that surface in causing a response in a detector within the shielding 
geometry, i.e., the “dose importance” of the coupling surface fluence.  A coupling code folds the 
fluence together with the dose importance, giving the desired dose response.  The coupling code 
can determine the dose response as a function of the shielding geometry orientation relative to 
the source, distance from the source, and energy response of the detector.” (Johnson, Emmett, 
Rhoades, & Childs, 1992). 
2.4. Fictitious scattering (Woodcock hole tracking) concept 
Besides the use of the hybrid forward/adjoint MASH-like surface coupling, this project also 
incorporates an improved particle tracking algorithm in the Monte Carlo calculations.  This is an 
improvement over traditional tracking approaches.  For both forward and adjoint Monte Carlo 
traditional tracking algorithms, the computational performance of the simulation is poor for 
heterogeneous voxelized phantoms because the particle mean free path lengths (i.e., the average 
distance travelled between collisions) vary between regions forcing the particle tracking 
algorithm to spend time locating intersections of the particle track with region boundaries.  We 
can reduce the computer time spent on particle tracking for photons in a voxelized phantom by 
using fictitious interaction tracking (also known as Woodcock tracking).  Fictitious interaction 
tracking is a sampling technique useful when the transported particles have a relatively large 
mean free path length in comparison to the dimensions of the problem geometry (Brown & 
Martin, 2003).  This technique is also called Woodcock tracking (Carter, Cashwell, & Taylor, 
1972; Cramer, 1977; Kawrakow & Fippel, 2000; Woodcock, Murphy, Hemmings, & Longworth, 
1965) or delta scattering (Ljungberg, Larsson, & Johansson, 2005; Tenney, Bowsher, & 
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Jaszczak, 2004).  This sampling technique is expected to lead to more efficient means of 
transporting beam photons through a voxelized phantom (in both forward and adjoint modes). 
2.4.1. Why fictitious scattering works 
In a heterogeneous medium the mean free path is not constant.  As a result boundary tracking 
is necessary and it will consume a lot of computer time.  Reduction in computer time can be 
achieved using the fictitious scattering tracking method.  The fictitious scattering method make 
the mean free path within a multi material region constant eliminating the boundary tracking step 
from the calculation.  Fictitious scattering is implemented by using the problem largest total 
linear attenuation cross section Σ when transporting the particles between interaction sites.  
This is equivalent to adding extra linear attenuation cross section artificially to the actual total 
linear attenuation cross section for all region materials.  For a problem with several materials the 
maximum total linear attenuation cross section is given by: 
  
, , , ⋯ , or 
  
 # 
`   # `   # `  ⋯   # ` 
In the formula above Σ
`, Σ`, Σ`, ⋯ , Σ` are artificial cross-sections added to achieve the 
constant linear attenuation cross section.  As a result the total number of particle collisions is 
increased but the distribution of real particle collisions remains unchanged. 
Define % as the intensity of particles at a point  along an axis, and Σ& is the total 
attenuation cross section of region.  The amount of particles removed due to collisions in ' 
from the beam is: 
# )*+,-./0 */123/' '4/ +2 */. -2..,0,250   %6&'7. 
The particles intensity after traversing ' along the axis is: 
% # '  % 9  %6&'7    %1 9  &' 
Using the maximum total attenuation cross section of the problem fictitious cross section is: 
Σ;&<&&=>   Σ 9 Σ& 
The amount of particles removed fictitiously at same location is: 
#  )*+,-./0 */123/' '4/ +2 ?,-+,+,240 -2..,0,250   %6Σ 9 Σ&'7 
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Then the accurate particles intensity after traversing ' along the axis is using the maximum 
total attenuation cross section of the problem is:  
% # '  % 9  %6'7 # %6 9 &'7 
% # '  %@1 9 ' # ' 9 &'A 
% # '  %@1 9 &'A 
We can also derive the first equation from the above equation.  Therefore, both equations are 
equivalent and hence the distribution of real collisions is conserved. 
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  Chapter 3
Project objective 
 
Due to the increased use of Monte Carlo methods in medical physics as an absorbed dose 
evaluator, this research aims at building software to aid in more efficient planning of cancer 
patient treatments.  Because the traditional use of the Monte Carlo method is too slow for clinical 
use, our objective is to demonstrate the viability of a hybrid forward/adjoint Monte Carlo 
technique for faster absorbed dose computations. 
Our objective was to build a set of Monte Carlo codes capable of calculating forward and 
adjoint Monte Carlo problems and to adapt them to hybrid forward/adjoint use; this will aid in 
the design of optimized patient treatment plans.  For validation, we set out to demonstrate that 
the forward and hybrid approach yields the same results (within statistical error).   
For increased efficiency, this objective was accomplished by implementing several Monte 
Carlo techniques that have been shown useful in deep penetration and reactor analysis, but have 
not yet been applied to radiation therapy.  These techniques are: 
1. Replacing the conventional ray tracing method used to track adjoint particles with 
the “Fictitious Scattering” (commonly known as “Woodcock Tracking”) method 
on a dedicated regular Cartesian grid.  This has been shown to be effective for 
problem geometries with material cells smaller than particle mean free paths, 
which should make it an efficient technique to use with spatial geometries 
described by CT-image-based Cartesian voxels. 
2. Implementing the hybrid forward/adjoint capability by interfacing the external 
conical beam source with a calculated adjoint surface sensitivity through an 
integration procedure to predict absorbed dose in specified internal structures.  
The adjoint method, commonly used in the reactor physics and radiation shielding 
design, are used to produce the surface adjoint fluxes (which serve as flux-to-dose 
response functions for the region of interest used as the adjoint source. 
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In order to harvest the usefulness of the adjoint method for a specific geometry (patient) we 
will: 
1. Calculate (starting from the tumor volume) an adjoint flux φ>=C∗ *, Ω, F on 
each external surface of the patient body (or a box containing the patient body) as 
a function of surface, pixel, direction and energy. 
2. Similarly calculate the adjoint flux φGHI∗ *, Ω, F on each external surface for 
each other region of interest (e.g., organ at risk). 
3. Fold the computed adjoint fluxes φ>=C∗ *, Ω, F and φGHI∗ *, Ω, F with the 
result of a forward transport of source particles to each visible patient surface to 
compute an estimate of the delivered absorbed dose to the regions of interest. 
This will represent the first time that either of these techniques have been used in a medical 
physics application.  Our objective is to demonstrate the viability of the approach and prepare the 
way for future optimization and application in the field. 
 
  
22 
 
  Chapter 4
Methodology used in the Project 
In this chapter, descriptions and derivations will be provided for the techniques that we use in 
this project: 
1. A general derivation of the multigroup Boltzmann equation with a description of 
Monte Carlo algorithms used to simulate photon transport. 
2. Application of fictitious scattering to particle tracking. 
3. Application of the hybrid forward/adjoint coupling for dose determination. 
4.1. Boltzmann transport equation for non-multiplying media 
As a radiation particle traverses a medium, it interacts via different mechanisms with the 
medium.  As a result and depending on the particle energy, the particle releases some or all of its 
energy as it is either absorbed or scattered to a new energy and direction.  The amount of energy 
in joules that a kilogram of the medium absorbs from the released energy at interaction sites is 
defined as absorbed dose.  Absorbed dose can be computed from an estimate of radiation fluxes 
in the interaction multiplied by a flux-to-dose conversion factor.  Therefore, estimation of fluxes 
in different regions in space will enable us to predict absorbed dose at those locations. 
The Boltzmann transport equation provides the mathematical relationship between radiation 
particles and the medium they are interacting with.  The transport equation describes the balance 
of particles entering and leaving a differential volume in space, energy, and direction.  As a 
result, it relates mathematically medium radiological properties to radiation particle interaction 
mechanisms.  Our research is focused on “photon systems where no fissionable isotopes are 
present” hence non-multiplying media (Lewis & Miller, 1984).   
4.1.1. Continuous form of the time dependent Boltzmann transport equation 
The continuous time-dependent form of the transport equation is: 
 
 
(4-1) 
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The term SKrL, ΩM, E, tP is the source term and it accounts for all particle sources in the medium.  
SKrL, ΩM, E, tP is the sum of all particle sources such as sources embedded in the medium (external 
sources), scattering events and fission reactions within the system.  Mathematically this is 
written as:  
QK*L, RS, F, +P    QTK*L, RS, F, +P  
# U 'FVW U 'RS XY Z<[\&>K*L, RS  → RS, F → FP]K*L, RS , F, +P    
# ^F  U 'F∞0 U 'RS4b c ?,00,25 d*eL, F′g  ]*L, F, + 
The term ΩM ∙ ijφrL is the streaming operator defined by: 
ΩM ∙ ij]*eL  ≡  ΩM ∙ ,l m]*eLm # ΩM ∙ nl m]*eLmo # ΩM ∙ pM m]*eLmq  
with 
r  Particle velocity. 
s eeL  Particle position vector. 
tKseL, uM, v, wP   Particle angular flux. 
xw  Differential time.  
yM   Direction of particle. 
z j  Del operator. 
{|}w~xseL, v   Medium total cross section (attenuation coefficient). 
KseL, yM, v, wP   The combined source term. 
vwKseL, uM, v, wP   External fixed source. 
{~wwxKseL, uM  → uM, v → vP   Scattering cross section. 
v   Fission neutrons energy spectrum. 
  Average number of neutrons released per fission. 
{}seL, v    Fission cross section. 
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Our project deals with steady-state dose production from a fixed, unchanging source, so we 
can remove time dependent terms from Equation (4-1) giving us the steady state transport 
equation: 
RS ∙ j]*eL  # 2+.1/',41*L, F ]*L, RM, F    QK*eL, RM , F, +P 
 
where 
QK*L, RS, FP    QTK*L, RS, FP  # U 'FVW U 'RS XY Z<[\&>K*L, RS  → RS, F → FP]K*L, RS , FP 
 
Or, in expanded form: 
RS ∙ ]*L  #  =[\&>*L, F ]K*L, RS, FP    QTK*L, RS, FP  # 
 U 'FVW U 'RS XY Z<[\&>K*L, RS  → RS, F → FP]K*L, RS , FP 
(4-2) 
We need to specify a boundary condition to solve this equation.  For our project, an escaping 
particle cannot re-enter the problem geometry; therefore, the boundary flux is zero for all 
incoming directions.  If we define the boundary surface normal as 5 and pointing outward, then 
the boundary condition is written mathematically as: 
]K*L>C<[ , RS, FP  0   ?2* 5 ∙ RS    0 (4-3) 
The 5 ∙ ΩM    0 condition indicates that the source particles are incoming with respect to the 
boundary surface normal 5 .  This translates to an angle of  90°      180° with surface 
normal. 
4.1.2. Multigroup form of the transport equation 
An exact solution of the time-independent energy dependent transport Equation (4-2) can be 
obtained by using the multigroup approximation (Duderstadt, 1976; Lewis & Miller, 1984).  In 
this approximation the particle energy is divided into  finite number of intervals, ∆F called 
“energy groups”; where F    0 and FW is sufficiently large that the number of particles at 
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higher energies is negligible.  The particles in group  are taken to be just the particles with 
energies between F and F
.  Normally the group number increases as the energy decreases.  
The group angular flux is defined as: 
]K*L, RSP    U 'F]K*L, RS, FP TT   U 'F]K*L, RS, FP   
We proceed by dividing the nonmultiplying and time-independent transport equation (4-2) 
into contributions from each group: 
U 'FVW     U 'F

	

 
Integrating between E  and E 
, we get  coupled groupwise balance equations: 
RS ∙ eL U 'F]K*L, RS, FP   # U 'F 2+.1/',41*L, F]K*L, RS, FP    U 'FQF+K*eL, RM, FP  
#  U 'F U 'F U 'RXY Z<[\&>K*L, F → F, RS  ∙ RSP]K*L, RS , FP

	

 
We need to assume that angular flux is separable in energy to express this equation in terms 
of the group fluxes.  We start by assuming that the angular flux can be approximated as the 
product of a known function of energy ?F and group flux ]K*L, RSP as follow: 
]K*L, RS, FP    ?F ]K*L, RSP,        ?2*  F     F ¡    F
 
Substituting this equation into the above equation, we get: 
RS ∙ eL ¢U 'F ?F  £ ]K*L, RSP   # U 'F 2+.1/',41*L, F?F ]K*L, RSP    U 'FQF+K*eL, RM, FP  
#  U 'F U 'F U 'RXY Z<[\&>K*L, F → F, RS  ∙ RSP?F ]K*L, RS P

	
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If we utilize the fact that the energy dependent weighting function ?F is normalized by the 
definition of the group flux as follow: 
¤ 'F?F    1  , 
the above formula simplifies to: 
RS ∙ eL ]K*L, RSP   # U 'F =[\&>*L, F?F ]K*L, RSP    U 'FQTK*L, RS, FP  
#  U 'F U 'F U 'RXY Z<[\&>K*L, F → F, RS  ∙ RSP?F ]K*L, RS P

	

 
If we define the group total cross sections as: 
=,[\&>*L    ¤ 'F=[\&>*L, F?F   , (4-4) 
the scattering cross section to group g from all other groups g  as: 
Z< [\&> K*L, RS  ∙ RSP    ¤ 'F ¤ 'F ¤ 'RZ< [\&>K*L, F → F, RS  ∙ RSP?FXY , (4-5) 
and the g group external source as: 
QTK*L, RSP    ¤ 'FQTK*L, RS , FP , (4-6) 
then the nonmultiplying and time-independent multigroup transport equation becomes: 
¦RS ∙ eL  #  =,[\&>*L § ]K*L, RSP  
 QTK*L, RSP #  U 'RZ< [\&>XY K*L, RS  ∙ RSP]K*L, RS P

	

 (4-7) 
4.1.3. Monte Carlo simulation of the Boltzmann equation  
The following is a simplified outline of the algorithm followed to complete a Monte Carlo 
history (Irving, 1971): 
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1. Starting with the given source distribution, select the initial position *L′ and initial 
group ′, and set initial weight to: 
¨/,©+   U '0Q0LVW

	

 
2. Choose distance, R, to next interaction site from the PDF: 
)ª  =,[\&>K*L′ # ªRS P / ¤ ∑ KCL« I ¬M P \I­®¯°±­²³´µ¶,·¸  
3. Set *L    *L′ # ªRS  
a. If *L is outside the system, particle escapes and history terminated. 
4. Adjust the particle weight for non-absorption weighting 
¨/,©+   ¹º*/3,240 ¨/,©+ » ∑ *L
1/',41Z<,∑ *L[\&>=,  
and contribute to your tallies. 
5. Decide on new energy group and new direction 
a. Choose new group  from group to group scattering ratios  
b. Choose new direction from tabulated μ value for the selected new group. 
6. If new weight is below cutoff weight terminate history, otherwise  
a. Set *L′   *L  
b. Set ′    
7. Go to step 2. 
 
4.2. Applying fictitious scattering to the Boltzmann transport equation 
4.2.1. Derivation of Boltzmann transport equation with fictitious scattering 
The fictitious scattering (Woodcock Tracking) general model is developed by finding the 
distance to the next collision site assuming that the entire system is homogenous with one total 
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cross section Σ=,Z½[ per group for all the system materials at all spatial points.  It is 
“implemented by requiring Σ=,Z½[ to be spatially independent and when practical, to be greater 
than or equal to the largest cross section in the system” Σ¾¿À (Cramer, 1977).  We start with 
the conventional nonmultiplying and time-independent multigroup transport equation (4-7) and 
add the fictitious collision term Σ=,Qo0+/1 *L ]K*L, RSP to both sides of the equation: 
RS ∙ eL ]K*L, RSP # 2+.,[\&>*L]K*L, RSP #  =,Z½[*L ]K*L, RSP    QTK*L, RSP  
2+.,Z½[*L ]K*L, RSP #  U 'RZ< [\&>XY K*L, RS  ∙ RSP]K*L, RS P 

	

 
If we move the term =,[\&>*L]K*L, RSPto the right side and collect terms, this becomes: 
RS ∙ eL ]K*L, RSP  #  =,Qo0+/1*L ]K*L, RSP    QF+*L, RM 
#Á=,Z½[*L 9 =,[\&>*LÂ]K*L, RSP 
               #  U 'RS Z< [\&>XY K*L, RS  ∙ RSP]K*L, RS P 

	

 
(4-8) 
We next rewrite the second term on the right hand side of the equation as: 
Á=,Z½[*L 9 2+.,[\&>*LÂ]K*L, RSP   =,Z½[*L]K*L, RSP Ã1 9  =,
[\&>*L
=,Z½[*L Ä  
Using the definition of the Dirac delta function, the last term of (4-8) can be written as: 
 U 'RS  Å=,Z½[ *L Ã1 9 =,
1/',41 *L
=,Z½[ *LÄ  ÆKRS 
 → RSPÇ ]K*L, RS PXY

	

 
And for the scattering cross section we can separate out the angular redistribution PDF to get: 
Z< [\&> K*L, RS  ∙ RSP    Q-++ [\&>*L  ?KRS  ∙ RSP 
Substituting all of this back into (4-8) and collecting the terms yields: 
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RS ∙ eL ]K*L, RSP  # =,Qo0+/1 *L ]K*L, RSP      QTK*L, RSP 
 #  U 'RÈZ<,[\&> *L  ?KRS  ∙ RSPXY  

	

 
 # =,Z½[ *L Ã1 9  =,
1/',41 *L
=,Z½[ *LÄ  ÆKRS 
 → RSPÇ  ]K*L, RS P 
(4-9) 
Factoring out the =,Z½[*L term from the square bracket to the right of equation (4-9) will 
result in the following: 
RS ∙ eL ]K*L, RSP  # =,Qo0+/1 *L ]K*L, RSP   QTK*L, RSP  
 #  U 'R ÅZ<,[\&> *L=,Z½[ *L  ?KRS
 ∙ RSPXY

	

 
# Ã1 9  =,[\&>*L=,Z½[ *LÄ  ÆKRS 
 → RSPÇ =,Z½[ *L]K*L, RS P  
(4-10) 
Rewrite the term 
ÉÊËÌÍÍ,ÎÎÏÐÑÒÓÏ ÔeL
ÉÕÖÍÌ×,ÎÊØÙÍÐÏÔeL   as follow: 
Z<,[\&> *L=,′Z½[*L    
2+.,′[\&>*L=,′Z½[*L  Ú
Z<,[\&> *L=,′1/',41 *L  (4-11) 
And define the fictitious collision density term ψ ÜÝÞßàKrL, ΩMP as: 
áZ½[K*L, RS P   =,Z½[ *L]K*L, RS P (4-12) 
Similar to equation (4-12), the real collision density term ψ  âàãKrL, ΩMP is: 
á I[K*L, RS P    =,[\&>*L]K*L, RS P (4-13) 
Then the ratio of the real collision rate to the fictitious collision rate becomes:  
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á I[K*L, RS Pá Qo0+/1K*L, RS P    
=,[\&>*L =,Z½[ *L (4-14) 
and the real collision rate in terms of the fictitious collision rate is: 
á I[ ¹*eL, RM ′»    2+.,
1/',41*eL
 2+.,Qo0+/1 *eL  á 
Qo0+/1 ¹*eL, RM ′» (4-15) 
Substituting (4-11) and (4-12) back into (4-10) we get: 
RS ∙ eL ]K*L, RSP  # =,Z½[*L ]K*L, RSP    QTK*L, RSP 
#  U 'R Å=,[\&>*L=,Z½[ *L  Ú
Z<,[\&> *L=,1/',41 *L  ?KRS  ∙ RSPXY  

	

 
# Ã1 9  =,[\&>*L=,Z½[ *LÄ ÆKRS 
 → RSPÇ á Qo0+/1K*L, RS P 
(4-16) 
Multiplying ψ  ÜÝÞßàKrL, ΩMP into the right hand bracket and using (4-15), becomes equation 
(4-17): 
RS ∙ eL ]K*L, RSP  # Σ=,Z½[*L ]K*L, RSP    QTK*L, RSP 
#  U 'R ÅZ<,[\&> *L=,1/',41 *L   Ú  á I[K*L, RS P  Ú  ?KRS  ∙ RSPXY  

	

 
# Ã1 9  =,[\&>*LΣ=,Z½[ *LÄ ÆKRS 
 → RSPá Qo0+/1K*L, RS PÇ 
(4-17) 
The right hand side of equation (4-17) at ΩM  → ΩM  is the emergent particle density for all 
events (source real collisions, and fictitious collisions), which we can designate as q ÜÝÞßà: 
åZ½[K*L, RS P     ÅZ<,
[\&> *L
=,1/',41 *L

 	 

  Ú  á I[K*L, RS P  (4-18) 
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#  Ã1 9 =,1/',41 *L=,Z½[ *LÄ  á 
Qo0+/1K*L, RS Pæ 
Since, the emergent particle density for source real collisions is å  : 
å K*L, RS P    Z<,
[\&> *L
=,1/',41 *L

	

 á I[K*L, RS P  (4-19) 
Or, as shown in equation (4-10), is also equal to: 
å K*L, RS P    Z<,
[\&> *L
=,Z½[ *L

	

 á Qo0+/1K*L, RS P  (4-20) 
Substitute equation (4-19) into equation (4-18) to get 
åZ½[K*L, RS P    å K*L, RS P  #  Ã1 9 =,
1/',41 *L
=,Z½[ *LÄ

	

  á Qo0+/1K*L, RS P (4-21) 
The angular flux is computed from equations (4-12) and (4-13): 
]K*L, RS P     á 
Qo0+/1K*L, RS P
=,Z½[ *L

	

    á I[K*L, RS P =,[\&>*L

	

  (4-22) 
All of the above equations are valid when the absorption weighting Monte Carlo method is 
used to find a solution.  Further, for this type of transport (absorption weighting) the real 
emergent density å K*L, RS P is given by: 
å K*L, RS P    Z<,
[\&> *L
=,1/',41 *L

	

 á I[K*L, RS P  
                        Z<,[\&> *L=,Z½[ *L

	

 á Qo0+/1K*L, RS P 
(4-23) 
And the fictitious emergent density is: 
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åZ½[K*L, RS P     ÅZ<,
[\&> *L
=,Z½[ *L  # Ã1 9  
=,1/',41 *L=,Z½[ *LÄÇ

	

á Qo0+/1K*L, RS P (4-24) 
And using (4-23) and (4-24) the flux is: 
]K*L, RS P    åK*L, RS PZ<,[\&> *L

	

 
           åZ½[K*L, RS P
∑ ÅZ<,[\&> *L  # =,Z½[ *L Ã1 9  =,
1/',41 *L
=,Z½[ *LÄÇ
	

 (4-25) 
4.2.2. Use of fictitious scattering in Monte Carlo algorithms 
When implementing the fictitious scattering method, the distance to the next interaction site 
is computed using fictitious cross section =,Z½[*L.  If the interaction site is within the 
problem boundary, we determine if the interaction is real or fictitious based on the ratio between 
the true site attenuation coefficient and the fictitious cross section.  A true scattering interaction 
occurs with a probability of  ∑ CL ­®¯°±­²³´µ¶,ç²³´µ¶,èéê´®­CL , which indicates that a real scattering event has taken 
place with an absorption weighting correction applied.  Otherwise, with probability of ë 1 9
∑ CL ­®¯°±­²³´µ¶,
ç²³´µ¶,èéê´®­CL ì a fictitious interaction occurred and the particle continues on the same path without 
any change of direction, energy and weight. 
The fictitious scattering method is implemented using a random number to determine if each 
collision is real or fictitious (random number RN are uniformly distribution in the interval 
0 ¡  ªí ¡  1 ).  The algorithm is: 
1. Choose a fictitious cross-section =,Z½[*L.  This is normally chosen to be the 
largest expected cross section value during any particle flight. 
2. Sample trial flight distance using : 
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)ª  =,Z½[ K*L′ # ªRS P / ¤ ∑ KCL I ¬M P \Ièéê´®­²³´µ¶,·¸  
3. Move the particle that distance and find ∑ *L [\&>=,  at the new location. 
4. Compute º   ∑ CL ­®¯°±­²³´µ¶,ç²³´µ¶,èéê´®­CL . 
5. Draw a random number RN and test for type of collision: 
a. A real collision occurs if ªí ¡  ∑ CL ­®¯°±­²³´µ¶,ç²³´µ¶,èéê´®­CL  and ordinary collision 
mechanisms are used to determine post collision parameters: 
i. New photon Energy; 
ii. New particle direction. 
b. A fictitious collision occurs if  î  ∑ CL ­®¯°±­²³´µ¶,ç²³´µ¶,èéê´®­CL  , and the particle continues with 
the same direction, energy, and particle weight. 
The fictitious scattering tracking becomes inefficient if =,Z½[*L is much larger than the 
typical cross-section; otherwise it is a very powerful Monte Carlo technique.   
For adjoint transport, the fictitious scattering algorithm is the same. 
4.3. Hybrid forward/adjoint technique 
The hybrid forward/adjoint technique is best described using operator notation for the 
forward and adjoint transport. We start by defining the traditional forward solution of the 
transport equation as a groupwise solution of the forward operator: 
ï ]K*L, RSP    QK*L, RSP 
where: 
ï ≡ RS ∙ eL  #  Σ=,ð[\&>*L 9   U 'RZ<,[\&> K*L, RS ∙ RS′PXY  

	
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For a standard shielding problem with both sources and detectors located inside the system 
boundary and non-reentrant boundaries, the forward flux solution is found for zero inward 
boundary flux: 
]K*L>C<[, RSP   0   ?2* 5 ∙ RS   0   ?2* ..  *L  ∈   Q4*?-/ 
Once we have an estimate of ]K*L, ΩMP we then fold it into the detector response function 
ªK*L, RSP, to get the desired response in the volume (i.e., Absorbed Dose ò ) using: 
ò   U 'óô  U 'RS ]K*L, RS P ªK*L, RS P    〈], ª〉XY

	W
 (4-26) 
The “bra-ket” notation used in equation (4-26) is a simple way to express full integration (or 
summation) over all independent variables. 
Similarly, we can define a solution of the adjoint transport equation as a groupwise solution 
of the adjoint operator: 
ï∗    ]∗ K*L, RSP    ªK*L, RSP 
where 
ï∗ ≡ 9RS ∙ eL  #  Σ=,ð[\&>*L 9   U 'RZ<,[\&> K*L, RS ∙ RS′PXY  

	

 
 
 
The reason for the use of the response function for the adjoint source becomes apparent when 
we consider that the mathematical relation between the forward and adjoint operators is given 
by: 
〈]∗ , ï ]〉    〈], ï∗ ]∗ 〉  # U 'óô  U 'RS RS ∙  Á]K*L, RS P]∗ K*L, RS PÂ XY

	W
 (4-27) 
The last term can be put in a more convenient form using the divergence theorem, which 
transforms a volume integral into a surface integral as follow: 
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U 'ó?K*L, RSPô     U 'Q 5?K*L, RSPZ  (4-28) 
Using the divergence theorem, Equation (4-27) can be written as: 
〈]∗ , ï ]〉    〈], ï∗ ]∗ 〉  # 〈 RS ∙ 5  ], ]∗ , 〉Z (4-29) 
where 
〈 RS ∙ 5  ], ]∗ , 〉Z  ≡  U 'QZ  U 'RS RS ∙ 5 ]K*L, RS P]∗ K*L, RS P XY

	W
 (4-30) 
The usefulness of this can be shown when we expand the definition of the dose rate (4-26): 
ò   〈]   , ª〉        〈]   , ï∗]∗〉                                  ?*21 'n2,5+ 02.4+,25 ,0 ï∗]∗   ª        〈 ]∗, ï]〉  9 〈5 ∙ RS  ] , ]∗〉Z    ?*21 2)/*+2*0 */.+,250©,)        〈]∗ , Q〉  9 〈5 ∙ RS  ] , ]∗〉Z       ?*21 ?2*÷*' 02.4+,25 ,0 ï]  Q    
(4-31) 
This terse but useful derivation shows that the dose rate in a region, which is normally 
calculated using the first line (i.e., by determining the flux with a forward calculation and then 
folding the flux with a response function in the region of interest), can also be found in two other 
ways, using the last line: 
1. If an adjoint-only calculation is performed with both the source region and response 
region within the boundary of the calculation and void boundary conditions used on a 
non-reentrant outer boundary, then the response rate is given by: 
*
,D Sϕ=
 
since the second term in the bottom line of Equation (4-31) goes to zero due to: 
]K*L>C<[, RSP   0   ?2* 5 ∙ RS   0   ?2* ..  *L  ∈   Q4*?-/ 
and 
]∗ K*L>C<[, RSP   0   ?2* 5 ∙ RS  ø  0   ?2* ..  *L  ∈   Q4*?-/  
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which means that their product is zero for all directions. 
2. If an adjoint calculation is performed which contains the detector, but not the source 
(i.e., the source particles arrive from outside by impinging on the boundary in an 
incoming direction), then the response rate is given by: 
*
ˆ
ˆ ,
S
D n ϕ ϕ= − ⋅ Ω  
(which will be positive since the directions are incoming). 
The second case above is the basis for the hybrid forward/adjoint technique. 
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  Chapter 5
Voxel8 and Pixel8 Code Algorithms 
 
The purpose of this chapter is to explain in detail the algorithms within the FORTRAN 
computer codes developed for this project.  The first three sections of this chapter give general 
outlines and flowcharts of the three modes developed: forward, adjoint, and hybrid 
forward/adjoint.  The last section covers the details of how the decisions are made at each of the 
decisions points of the Monte Carlo random walk. 
5.1. Forward mode  
5.1.1. Outline of the forward Monte Carlo code(Voxel8) 
Find the maximum total cross sections for each group 
For n = 1 to desired number of histories (NPS). 
1. Starting from initial source position, pick initial particle direction  within the 
primary collimator specified cone apex angle and set initial weight to the sum of 
the group sources (or to one and correct later). 
2. Compute intersection point  between the picked 
particle direction & plane defining adjustable field size. 
3. Test if  within adjustable field size or not 
• If NO, END THE HISTORY. 
4. Sample source energy group. 
5. Sample distance to collision site using the maximum total cross section. 
6. Compute collision site location . 
7. Test if the collision site is within the problem geometry: 
• If NO, END THE HISTORY 
8. Score flux-based tallies based on current energy group, weight, and the maximum 
total cross section as follow: 
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]   ù ¨/,©+=,Z½[*L ó ú  ,5 45,+0 ¹
1-1» 
 
9. Lookup the material at this collision site 
10. Compute Fictitious scattering probability 
11. Determine type of collision 
• If fictitious, continue the particle path unchanged (GOTO bullet 5). 
12. Lookup the following for the location site material and particle energy group: 
• Scattering probability. 
• Group to group CDF for scattering 
• Group to group cosine scattering angle data. 
13. Compute: 
• New particle weight based on scattering probability using  
¨/,©+   ¹º*/3,240 ¨/,©+ » ∑ *L
1/',41Z<,∑ *L[\&>=,  
• New energy group after scatter. 
• New direction of travel after scatter for this group-to-group transfer. 
                     (GOTO bullet 5). 
End 
Perform post-processing and output the results 
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5.1.2. Flow chart of the forward Monte Carlo code (Voxel8) 
 
Figure 5-1 Flow chart of forward Monte Carlo code (Voxel8) 
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5.2. Adjoint mode 
5.2.1. Outline of the Adjoint Monte Carlo code (Pixel8) steps 
Find the maximum total cross sections for each group 
For For n = 1 to desired number of histories (NPS). 
1. Sample initial position within ROI voxel from set boundaries W , oW , qW. 
2. Sample source energy group from the dose response function. 
3. Sample direction isotropically KΩMW , ΩM½W , ΩMûWP. 
4. Set particle initial weight to the sum of the group response function values (or to 
one and correct later). 
5. Sample distance to collision site using the maximum total cross section for the 
group. 
6. Compute the new location [ü ,  o[ü,  q[ü.  
7. Test if collision site [ü , o[ü, q[ü is within the problem geometry: 
• If NO, Figure out the following about the exited particle: 
 Which boundary surface the particle crossed. 
 Particle energy. 
 The surface pixel indexes at the point of exit. 
 The “igloo” zone according to particle direction. 
• Score to appropriate tally according to the parameters determined above 
• terminate history (GOTO bullet 15).  
8. Find the collision site voxel and look up: 
• Material. 
• Total cross section (given material and energy group). 
9. Compute fictitious scattering probability 
10. Determine type of collision 
• Fictitious, keep particle group, direction and weight (GOTO bullet 6). 
11. Lookup the following for the voxel material and particle energy group: 
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• Scattering probability. 
• Group to group CDF. 
• Group to group cosine scattering angle data. 
12. Compute: 
• New particle weight based on (sum of group-to-group Scattering cross sections 
for the current group)/Total cross section.  If the weight is below the Russian 
Roulette lower weight, then play Russian Roulette, ENDING the history if the 
particle fails. 
• New group after scatter. 
• New direction of travel after scatter. 
13. Set the new particle parameter values found in step 13. (GOTO bullet 6.) 
14. Figure out the following: 
• Which boundary surface the particle crossed. 
• Particle energy. 
• The surface pixel indexes at the point of exit. 
• The “igloo” zone according to particle direction. 
15. Contribute to the appropriate tally according to parameters determine from 
previous steps (surface, pixel index, energy group, igloo zone) the following 
(adjoint flux): 
]∗    ¹ ¨/,©+ý20 'þ »  45,+0 ¹-o-1» 
END  
Perform post-processing and output the results. 
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5.2.2. Flow chart of the Adjoint Monte Carlo code (Pixel8) 
 
Figure 5-2 Flow chart of adjoint Monte Carlo code (Pixel8) 
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5.3. Hybrid forward/adjoint mode 
5.3.1. Procedural steps for the surface integration 
Read the Adjoint Monte Carlo code results (Adjoint surface flux by (surface, pixel, energy 
group, directional bin). 
For 5  1 +2 '/0,*/' 541/* 2? ©,0+2*,/0 íºQ. 
1. Starting from initial source position pick initial particle direction ΩW within the 
primary collimator specified cone apex angle – set initial weight to sum of group 
source rates, wforward. 
2. Compute intersection point &[C[< , o&[C[< , q&[C[< on the patient 
surface. 
3. Test if &[C[< , o&[C[< , q&[C[<   is within the adjustable field size 
• If NO, discard this direction and choose another one (GOTO bullet 1).  
4. Sample source energy group. 
5. Locate appropriate (surface, energy, igloo direction) bin and retrieve the saved 
adjoint flux for the bin, wbin. 
6. Add contribution to the dose from this intersection as: 
∆ò   U 'Q  U 'RS∙¬MW

	
Z
5 ∙ RS]∗ K*L, RSP ] K*L, RSP ≅ ÷=CüC\ ∙ ÷& 
END 
Perform post-processing and output the results 
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5.4. Details of the decisions made in the random walks 
 
 
Figure 5-3 Random walk / history steps 
 
Figure 5-3  illustrates the events occurring during particle random walk in a medium (E. D. 
Cashwell & Everett, 1959) and are the bases of Monte Carlo simulation of radiation transport in 
a medium.  For the purpose of our project, this random walk is essentially the same in forward 
and adjoint Monte Carlo mode except at the start of the random walk and for the energy group 
determination after a scattering event. 
5.4.1. Selection of initial particle parameters 
5.4.1.1. Initial direction 
In forward mode, we start our transport by selecting an initial particle direction in the cone 
illustrated in Figure 5-4 (chosen so that it completely covers the adjustable field size window), 
with the particle immediately killed if it is not inside the adjustable field size window. The result 
is an initial direction choice within the adjustable field size window.  The passing particle will 
have an initial weight of: 
¨©+W   K1 9  ý20P2  
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Figure 5-4 Photon direction selection 
 
In adjoint mode, we start from a region of interest voxel (i.e., selecting a voxel index) where 
all voxels have the same probability.  Then a starting point x, y, z is selected inside the given 
geometrical boundary as follow: 
1. Q/./-+ *5'21 541/* 
 +©/5 -21)4+/  
 &    &  #  ' Ú  
. 
2. Q/./-+ *5'21 541/* 
½ +©/5 -21)4+/ 
o&    o&  #  'o Ú  
½. 
3. Q/./-+ *5'21 541/* 
û +©/5 -21)4+/ 
q&    q&  #  'q Ú  
û. 
Then we test if these coordinates are within the region of interest or not.  If they are we 
proceed if not we sample for another point.  Then an initial direction is selected by selecting the 
cosine of a polar angle and an azimuthal angle. Then these two values are converted to Cartesian 
coordinates. The steps are as follow: 
1. Q/./-+ *5'21 541/* 
 +©/5 -21)4+/  
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Rû       91.0 #  2.0 Ú 
  
2. Q/./-+ *5'21 541/* 
 +©/5 -21)4+/  
   2.0 Ú  b Ú 
  
3. ©/5 -21)4+/: 
1 9  
4.  & o ',*/-+,25 -21)25/5+: 
R    1 9  ý20 
R½    1 9  Q,5  
5.4.1.2. Initial energy  
Our research interest is the poly-energetic photon spectrum generated by a medical linear 
accelerator.  Description of this spectrum can be found in papers published by Mohan, Chui, and 
Lidofsky in 1985 and the paper by Sheikh-Bagheri and Roger in 2002 (Mohan, Chui, & 
Lidofsky, 1985; Sheikh-Bagheri & Rogers, 2002).  The latest paper by Sheikh Bagheri & Rogers 
(Mohan et al., 1985; Sheikh-Bagheri & Rogers, 2002) calculates and tabulates the photon 
spectrum using Monte Carlo simulation for nine beams from three major manufacturers of 
commercial medical linear accelerators with energies ranging from 4-25 MV at the source 
location.  The data is separated into two categories according to the linear accelerator maximum 
energy as high energy (energy between 15-25 MV) and low energy (4-10 MV).  Figure 5-5 is a 
plot of the computed photon spectrum for a low energy Linac while Figure 5-6 is a plot of the 
computed photon spectrum for a high energy Linac.  
In forward transport mode, the desired photon spectrum is selected.  The probability 
distribution function ºò and the cumulative probability distribution ýò are calculated and a 
search array is built.  The initial particle energy is selected from the CDF. 
   
47 
 
 
Figure 5-5 Low energy spectrum (4-10 MV) from Medical Linear Accelerator 
 
 
Figure 5-6 High energy spectrum (15-25 MV) from Medical Linear Accelerator 
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To speed up the initial energy selection process, a search array was built that bins the photon 
spectrum ýò into a known number of bins.  The number of search array bins reflects the 
desired search precision.  The current implementation uses a search array size of a 1000.  
Therefore, the search array bins index reflects the photon group ýò values multiplied by a 
1000.  The array itself holds the corresponding energy group value.  Once a group is selected it is 
verified against the actual photon ýò and adjusted accordingly.  Using the search array will 
eliminate the need to loop through the entire photon spectrum ýò every time we start a new 
history. 
Similarly in adjoint transport mode, the best guess about the adjoint source probability 
distribution is built from the response function before the start of transport.  The probability 
distribution function ºò and the cumulative probability distribution ýò are calculated and a 
search array is built.  During transport the initial adjoint particle energy is sampled from the 
search array then verified with the CDF. 
5.4.1.3. Sampling the distance to interaction / collision site Sampling  
 
 
Figure 5-7 Distance to collision site sampling 
 
Both the forward and adjoint transport use the same process to sample distance to collision 
site.  This process is illustrated in Figure 5-7.  Define the optical depth,  , as the expected 
number of mean free paths traversed by a particle traveling a distance  through a medium with 
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arbitrarily specified macroscopic cross-section Σ (Carter & Cashwell, 1975; Carter et al., 
1972; E. Cashwell, Neergaard, Taylor, & Turner, 1972; E. D. Cashwell & Everett, 1959): 
   U W ' 
Assuming that Σ is finite and Σ  ø 0, the probability of traversing a distance  in a 
medium without collision event when  is 0 ¡    ∞  is: 
)*2,.,+o 2? +*3/*0,5  ',0+5-/    / 
The independent interaction probability per distance traveled event is:  
''     
which leads to 0 ¡ \\    ∞ .  
The probability density function (PDF) for a collision occurring after a particle travels a 
distance  through a medium is given by the product of the above two probabilities: 
ºò  ''  ∙  / 
Normalizing the result by integrating the equation yield the normalization constant  : 
   U ''  ∙  / '
V
W  1 9 /V 
To allow for particles that have no collisions (i.e., exit the problem geometry without 
interaction), we define the “no collision probability” º as: 
º  /V 
The normalization constant  becomes: 
   U ''  ∙  / '
V
W  1 9 /V  1 9  º  
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The probability density function ºò for a collision occurring after a particle travels a 
distance  through a medium can now be expressed as the sum of the two mutually exclusive 
events probability (probability of no interaction and probability of interaction at distance x) given 
by 
ºò   º ∙ Æ   ∞ #  ''  ∙  / 
If we use the fact that  
1   1 9 º1 9 º    1 9 º  ∙  
11 9 º  1 9 º  ∙  
1 
the probability density function (PDF) for a collision occurring after a particle travels a distance 
 through a medium is: 
ºò   º ∙ Æ   ∞ # 1 9 º  ∙  1  ∙  ''  ∙  / 
Note that the PDF equation allows for the possibility of traveling an infinite distance without 
colliding. These are cases that occur when Σ  → 0 as  →  ∞ (most often occurring when the 
solution volume is limited to a finite region and void assumed outside of this volume) 
Random sampling the Monte Carlo flight path requires solving the following equation for 0, 
the flight path distance to collision: 

   ¤ ºòW  '  or   
  ýò0 
where 
 is a uniform random number in @0, 1, ºò is given by the equations above, and the 
ýò is given by: 
ýò   U ýòW  '   º  ∙ , ∞ #  1 9 º  ∙  
1 9 /1 9 /V 
(with , ∞ the Heaviside step function). Frequently we write 0 as: 
0  ýò

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For the infinite homogenous medium case when the cross section is a constant and 
independent of  the optical distance equation simplifies to: 
   ,    \\   ,    º  0,      1,    ýò  /ç 
And the solution for 

   ¤ ýòW  '  or     
  ýòQ 
is 
Q   9 .51 9 
  
Since 
 and 1 9 
 are both uniform distributions between 0 and 1, the above equation is 
commonly implemented as:  
0   9 .5
  
As a particle traveling the medium enters a region with a different total cross section Σ, 
the sampled distance to the next collision 0 will vary.  When the value of 0 is larger than region 
dimensions we need to adjust 0 appropriately; this can result in a lot of computation time spent 
trying to figure out distances to boundaries.   
We can avoid this situation by utilizing the concept of factitious scattering method.  When 
using the fictitious scattering method, the material actual total cross section is replaced with a 
fictitious total cross section for the purposes of finding the distance to next collision. As 
described in Chapter 4, using the fictitious total cross section eliminates the need to check and 
compute distances to current region boundaries, resulting in a computational time saving.. 
5.4.1.4. New particle position 
The particle’s new and old position is related by: 
[ü   =\ # Q R®  
o[ü   o=\ # Q R½®  
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q[ü   q=\ # Q Rû®  
The computed location is tested against the geometry boundaries to determine if the particle 
is still inside the geometry.  If the particle is still in the geometry, the transport continues; 
otherwise the history terminates and a new history is started.  Both the forward and adjoint 
methods use the same formula to compute the particle new position. 
5.4.1.5. Sampling the energy and direction following scattering events 
For the current particle energy, a cumulative probability values (CDF) are pre tabulated for 
all possible group-to-groups scatters for both transport modes.  These cumulative probability 
values are used to sample the new energy group after a scattering event.  Once the new to group 
is determined, the cosine of scattering angle is picked from a tabulated cumulative probability 
values for all possible cosine scattering angles for the particular group-to-group transfer (which 
are also precalculated).  The CDF is used to determine the cosine of the scattering deflection 
angle, .  
The new direction Ω[ü is computed using the relationship between the old direction, Ω=\, 
the deflection angle, , and a uniformly chosen azimuthal angle, ] as described by Carter and 
Cashwell (Carter & Cashwell, 1975): 
R=\   KR³¶¯ , R½³¶¯ , Rû³¶¯P 
R®   R³¶¯ý20 #  Q,51 9 Rû³¶¯
 KR³¶¯Rû³¶¯ý20] 9 R½³¶¯Q,5] P 
R½®   R½³¶¯ý20 # Q,51 9 Rû³¶¯
 KR½³¶¯Rû³¶¯ý20] #  R³¶¯Q,5] P 
Rû®   Rû³¶¯ý20 #  Q,51 9 Rû³¶¯
 K9¦1 9 Rû³¶¯ §ý20] P 
In Cartesian coordinates, the new direction is found using simple vector rotation.  The first 
rotation is around the positive y-axis then followed by a rotation around the z- axis. 
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Figure 5-8 Energy and direction sampling 
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  Chapter 6
Sample problems 
To validate the computer codes developed in this project, the following testing was done: 
1. A generic sample problem was defined involving an external beam source and a 
patient, modeled as a water cuboid with defined subregions to approximate the 
tumor, the brain, and the two eyes. In order to use MCNP5 multigroup option for 
validation, the MCNP5 12 group photon structure was employed and the Los 
Alamos computer code NJOY99 was used to generate the data.   
2. Comparison of the 12 group data with the standard multigroup interaction cross 
sections was performed for hydrogen, oxygen, and water reaction rates.  
3. A forward case was run with both MCNP 5 and the project code to compare the 
average fluxes in a vertical slice through the patient and to estimate the dose rates 
to the tumor and organs. 
4. An adjoint case was run with both MCNP5 and the project code to compare the 
surface adjoint fluxes (the actual surface fluxes for MCNP5 versus the average 
adjoint fluxes in the top layer of voxels for the project code). 
5. The surface adjoint fluxes using the project code in Step 5 were folded into the 
forward source used in Step 3 to implement the hybrid forward/adjoint 
methodology; the resulting dose rates in the tumor and the organs were compared 
to the doses calculated in Step 3. 
The details and results of these tests are given in this chapter. 
6.1. Common elements of the generic beam/patient sample problem  
6.1.1. Geometry/material map 
The codes require the material map be created by assigning voxel material indices to each 
element of a 3D (x,y,z) Cartesian grid. We can get this map either from CT data sets or built it 
from simple geometric shapes. For these sample problems, we defined a 50.0 cm x 50.0 cm x 
50.0 cm water filled box. The box is divided into voxels of 0.5 cm x 0.5 cm x 0.5 cm, resulting in 
a 100x100x100 voxel grid.  
The following is the used direction convention: 
55 
 
1. X-axis runs along the box width. 
2. Y-axis runs along the box depth. 
3. Z-axis runs along the box length. 
The top of the box is the most negative y plane. The furthest top left corner is the minimum 
box point and the furthest bottom right corner is the maximum box point. Using this 
configuration the origin (0.0, 0.0, 0.0) is at the center of the top layer.  
It is worth noting that this coordinate convention is used to describe medical images. For a 
set of 3-D medical images (e.g., computed tomography data) with the patient in the supine 
position (rested on his back) the following is the direction convention: 
1. The x-axis runs from right to left when examining one slice of data (transverse 
direction) with the negative direction at patient right side and positive direction at 
patient left side.  
2. The y-axis runs from top to bottom when examining one slice of data (axial 
direction) with the negative direction at patient bottom side (posterior position) 
and positive direction at patient top side (anterior position). 
3. The z-axis follow the patient mid line with the positive direction is at the patient 
superior end (head) and the negative direction is at the patient inferior end (feet).  
6.1.2. Radiation (forward) source 
6.1.2.1. Source energy 
The source is a photon polyenergetic source produced by a medical linear accelerator. The 
source distribution has a very well defined spectrum published by several authors. The source 
energy is designated as 6 MeV or 18 MeV. Source strength is defined at 100.00 cm away from 
source at a reference depth and field size (for a linear accelerator that is calibrated using source 
to phantom surface distance (SSD) method - a common calibration method - is 1.0 cGy / monitor 
unit at the selected energy maximum depth and 10.0 cm x 10 cm field size). 
Varian 6 MeV medical linear accelerator photon spectrum as published by (Sheikh-Bagheri 
& Rogers, 2002). The following are a plot and listing for the spectrum distribution of the Varian 
6 MeV photon beam:  
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Figure 6-1 Varian 6 MeV published spectra 
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Table 6-1 Varian 6 MeV published spectra 
Gamma 
Group # 
Energy Bin 
Upper Bound 
(MeV) 
Photons per 
MeV incident 
electrons PDF 
1 0.25 2.14E-05 0.020530 
2 0.50 1.26E-04 0.120877 
3 0.75 1.31E-04 0.125674 
4 1.00 1.14E-04 0.109365 
5 1.25 9.76E-05 0.093632 
6 1.50 8.36E-05 0.080201 
7 1.75 7.25E-05 0.069552 
8 2.00 6.23E-05 0.059767 
9 2.25 5.35E-05 0.051325 
10 2.50 4.59E-05 0.044034 
11 2.75 3.95E-05 0.037894 
12 3.00 3.47E-05 0.033289 
13 3.25 2.98E-05 0.028588 
14 3.50 2.61E-05 0.025039 
15 3.75 2.25E-05 0.021585 
16 4.00 1.91E-05 0.018323 
17 4.25 1.66E-05 0.015925 
18 4.50 1.38E-05 0.013239 
19 4.75 1.14E-05 0.010937 
20 5.00 9.04E-06 0.008672 
21 5.25 6.55E-06 0.006284 
22 5.50 4.09E-06 0.003924 
23 5.75 1.40E-06 0.001343 
24 6.00 4.34E-08 0.000042 
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Figure 6-2 Varian 6 MeV spectra adjusted to MCNP5-MGXSNP structure 
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Table 6-2 Varian 6 MeV spectra adjusted to MCNP5-MGXSNP structure 
Gamma 
Group # 
Energy Bin 
Upper Bound 
(MeV) 
Photons per 
MeV incident 
electrons PDF 
1 0.010 0.000000 0.000000 
2 0.100 8.025E-06 0.007698 
3 0.500 1.394E-04 0.133707 
4 1.000 2.450E-04 0.235028 
5 2.000 3.160E-04 0.303138 
6 3.000 1.736E-04 0.166534 
7 4.000 9.750E-05 0.093532 
8 5.000 5.084E-05 0.048771 
9 6.000 1.208E-05 0.011591 
 
Note: The photons are produced as a result of slowing down electrons in a 
tungsten target (bremsstrahlung spectrum). The produced bremsstrahlung 
spectrum is forwardly peaked and is collimated to produce a maximum 
square field of 40.0 cm x 40.0 cm at 100.0 cm downstream from the target. 
The energy upper bound is in MeV and the PDF will be used to model the 
source distribution in MCNP5. 
6.1.2.2. Source position and direction 
The physical source used in actual radiation treatment can be at any position around the 
phantom / patient via simple source rotation. The radiation field boundary (field size) is defined 
at 100.0 cm away from the source by either a set of jaws and / or by multi leaf collimator. The 
outer radiation field shape can be squares or rectangles by adjusting the jaws from 1.0 cm x 1.0 
cm up to 40.0 cm x 40.0 cm. The inner field shape can is modified using multi leaf collimator to 
further collimate the shape of the radiation field to conform to desired targets. 
For a coplanar (same - one – plane normally designated XY) beam arrangement we will have 
one plane (X-Y). For each beam we will always have one central axis (CAX) and iso-center 
(machine physical center and treatment center). This illustrated in the Figure below: 
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Figure 6-1 Coplanar beam arrangement 
 
The following is an illustration of source position around the phantom: 
 
 
Figure 6-2 Source position around phantom 
 
For these sample calculations, the source is positioned at 100.00 cm directly above the water 
box center. The particles travel straight down and limited to ~ 11.30993 cone from the source. 
The following is illustration of the coordinate convention used throughout the code.  
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Figure 6-3 Problem coordinate convention 
 
6.1.2.3. Source shaping 
The forward source simulates the linear accelerator jaws by defining a 10.0 cm x 10.0 cm 
square field projected on the top of the water box. This is model in MCNP5 by creating two 
0.001 cm thick void cells covering the entire water box surface. The result is a very thin 10.0 cm 
x 10.0 cm void window centered above the water box. The photon particle importance is set to 1 
inside the window and 0 outside the window.  
6.1.3. Simple geometrical region of interest (box) 
This sample problem a simple region of interest in shape of a small box (for which the dose 
is desired) was defined inside the water box.  The following is the geometric description of this 
region of interest: 
A. Shape: Box. 
B. Size: 1.5 cm x 1.5 cm x 1.5 cm. 
C. Location: The box is centered at (0.25, 5.75, 0.25), the X-range & Z-range = 
[-0.50, 1.0] and the Y-range = [5.0, 6.5]. 
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Pixel8 code will calculate surface crossings at each surface pixel.  The surface crossings are 
separated in position, direction and energy.  These separations in position (deltas in each surface 
direction) and direction (igloo zone division) are specified in the problem input file. 
6.1.4. Patient regions of interest 
In the sample problems, inside the water box, four regions of interest (for which the dose is 
desired) were defined: Tumor, Right eye, Left eye, and Brain.  The following is the geometric 
description of each structure: 
1. Tumor: 
D. Shape: Sphere. 
E. Size: Sphere radius = 3 pixels (1.5 cm). 
F. Location: The sphere starts on slice 55 and end at slice 60. The sphere 
center is at the end of slice 57 and at the end of 59th x-pixel and 30th y-pixel 
placing the structure geometric center at (4.5, 15.0, 3.0) cm. 
2. Right Eye: 
A. Shape: Sphere. 
B. Size: Sphere radius = 7 pixels (3.5 cm). 
C. Location: The sphere starts on slice 44 and end at slice 57. The sphere 
center is at the end of slice 50 and at the end of the 36th x-pixel and 8th y-
pixel placing the structure geometric center at (-7.0, 4.0, 0.0) cm. 
3. Left Eye: 
A. Shape: Sphere. 
B. Size: Sphere radius = 7 pixels (3.5 cm). 
C. Location: The sphere starts on slice 44 and end at slice 57. The sphere 
center is at the end of slice 50 and at the end of the 64th x-pixel and 8th y-
pixel placing the structure geometric center at (7.0, 4.0, 0.0) cm. 
4. Brain: 
A. Shape: Three rectangular boxes combine to make the final structure. 
B. Size: 
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i. Box one: width = 40 pixels (20.0 cm) and height = 25 pixels (12.5 cm) 
and length = 20 pixels (10.0 cm). 
ii. Box two: width = 40 pixels (20.0 cm) and height = 15 pixels (7.5 cm) 
and length = 14 pixels (7.0 cm). 
iii. Box three: width = 40 pixels (20.0 cm) and height = 55 pixels (27.5 
cm) and length = 13 pixels (6.5 cm). 
C. Location: 
i. Box one: Starts at end of slice 32 (z = -9.0 cm) and ends at the end of 
slice 52 (z =1.0 cm), the box top x & y pixel 30 (x = -10.0 cm) & 34 (y 
= 17.0 cm) and the box lower x & y pixel 70 (x = 10.0 cm) & 59 (y = 
29.5 cm). 
ii. Box two: Starts at the end of slice 52 (z = 1.0 cm) and ends at slice 66 
(z = 8.0 cm), the box top x & y pixel 30 (x=-10.0cm) & 42 (y = 21.0 
cm) and the box lower x & y pixel 70 (x = 10.0 cm) & 57 (y = 28.5 
cm). 
iii. Box three: Starts at the end of slice 66 (z = 8.0 cm) and ends at slice 80 
(z = 15.0 cm), the box top x & y pixel 30 (x = -10.0 cm) & 7 (y = 3.5 
cm) and the box lower x & y pixel 70 (x = 10.0 cm) & 62 (y = 31.0 
cm). 
Table 6-3 and Table 6-4 summarize the pixel locations of these brain structures and 
the corresponding actual (x,y,z) dimensions. 
 
Table 6-3 Summary of the brain components pixel location 
 
&  
Pixel 
 
Pixel 
&  
Pixel 
 
Pixel 
&  
Pixel 
 
Pixel 
Box one 30 70 34 59 32 52 
Box two 30 70 42 57 52 66 
Box three 30 70 7 62 66 80 
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Table 6-4 Summary of the brain components actual location 
 
 
cm 
~  
cm 
  
cm 
~  
cm 
   
cm 
 ~  
cm 
Box one -10.0 10.0 17.0 29.5 -9.0 1.0 
Box two -10.0 10.0 21.0 28.5 1.0 8.0 
Box three -10.0 10.0 3.5 31.0 8.0 15.0 
 
Figure 6-4 gives a pictorial representation of the location of the regions of interest in the 
sample problems. 
 
 
Figure 6-4 Plots of location of the regions of interest in the sample problems 
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6.1.5. Response function (adjoint source spectrum) 
The response function used for the forward dose calculation (by multiplying by flux 
contributions in the regions as particles collide in them) and also for the initial adjoint source 
photon spectrum was created for the sample problems by numerically integrating a published 
Varian 6 MeV response function (shown in Table 6-5) over the 12-group structure used in the 
sample problems.  The resulting 12-group response function is given in Table 6-6 Varian 6 MeV 
photon Response function (MCNP5-MGXSNP)Table 6-6, 
 
Table 6-5 Varian 6 MeV response function (published structure) 
Gamma 
Group # 
Energy bin 
upper bound 
(MeV) 
Response 
Function 
(cGy-cm2) 
1 0.25 5.23780E-10 
2 0.50 1.50459E-09 
3 0.75 2.60158E-09 
4 1.00 3.54905E-09 
5 1.25 4.37346E-09 
6 1.50 5.11610E-09 
7 1.75 5.79888E-09 
8 2.00 6.44136E-09 
9 2.25 7.01251E-09 
10 2.50 7.59904E-09 
11 2.75 8.09581E-09 
12 3.00 8.58734E-09 
13 3.25 9.10125E-09 
14 3.50 9.55186E-09 
15 3.75 9.99510E-09 
16 4.00 1.04792E-08 
17 4.25 1.09187E-08 
18 4.50 1.13250E-08 
19 4.75 1.18073E-08 
20 5.00 1.22876E-08 
21 5.25 1.27357E-08 
22 5.50 1.31545E-08 
23 5.75 1.35449E-08 
24 6.00 1.39088E-08 
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Table 6-6 Varian 6 MeV photon Response function (MCNP5-MGXSNP) 
Gamma 
Group # 
Energy bin 
upper bound 
(MeV) 
Response 
Function 
(cGy-cm2) 
1 0.010 3.12689E-10 
2 0.100 9.90001E-10 
3 0.500 3.00098E-09 
4 1.000 5.29621E-09 
5 2.000 7.76637E-09 
6 3.000 9.74813E-09 
7 4.000 1.15586E-08 
8 5.000 1.33190E-08 
9 6.000 1.49516E-08 
 
6.2. Verification of 12-group data from NJOY99 
The Pixel8 and Voxel8 programs use groupwise interaction and heat deposition cross 
sections produced by the Los Alamos NJOY99 code, which gets its basic energy-dependent cross 
sections from the readily available evaluated nuclear data format (ENDF) data files.  
To verify the data used in the sample calculations, a comparison was made between multi-
group microscopic cross sections generated by NJO99 and multigroup cross sections data 
extracted from the MCNP-MGXSNP cross sections files provided with the MCNP5 code for 
hydrogen (1000.01g) and oxygen (8000.01g).  
The following reactions were extracted for each of the isotopes: 
1. Total cross section (MT = 501). 
2. Coherent scattering cross section (MT = 502). 
3. Incoherent scattering cross section (MT = 504). 
4. Pair production cross section (MT = 516). 
Table 6-7 through Table 6-14 show the comparison between the given reaction rates for the two 
isotopes. The comparison for the first three reactions (i.e., excluding pair production) is 
excellent, with only a single value with an error above 1%, this being in the lowest energy group 
for oxygen (probably due to a difference in the physical models for treating low energy photon 
reactions like fluorescence and Bremsstrahlung).  Larger difference are seen for the pair 
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production cross sections, but the absolute values of the cross section indicate that this reaction is 
just a few percent of the scattering cross section for the energy groups with high errors; the effect 
of these differences on the dose calculation should be small. 
In summary, this comparison indicates that NJOY99 is being used correctly to create the 
cross sections.  
 
Table 6-7 Hydrogen MCNP5 versus NJOY99 microscopic total cross section 
Gamma 
Group # 
Energy 
Bin Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 4.99585E-02 5.00082E-02 0.10% 
2 9 6.03208E-02 6.03286E-02 0.01% 
3 8 6.53167E-02 6.52400E-02 0.12% 
4 7 7.16049E-02 7.15598E-02 0.06% 
5 6 7.97787E-02 8.00025E-02 0.28% 
6 5 9.07175E-02 9.05768E-02 0.16% 
7 4 1.06286E-01 1.06199E-01 0.08% 
8 3 1.30708E-01 1.31149E-01 0.34% 
9 2 1.77736E-01 1.78039E-01 0.17% 
10 1 2.49298E-01 2.49748E-01 0.18% 
11 0.5 3.91364E-01 3.92704E-01 0.34% 
12 0.1 5.25555E-01 5.26634E-01 0.21% 
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Table 6-8 Hydrogen MCNP5 versus NJOY99 microscopic coherent cross  
Gamma 
Group # 
Energy 
Bin Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 3.67705E-08 3.69064E-08 0.37% 
2 9 6.45139E-08 6.47800E-08 0.41% 
3 8 8.31110E-08 8.32596E-08 0.18% 
4 7 1.10860E-07 1.11264E-07 0.36% 
5 6 1.55268E-07 1.55795E-07 0.34% 
6 5 2.33669E-07 2.34701E-07 0.44% 
7 4 3.91946E-07 3.92837E-07 0.23% 
8 3 7.93448E-07 7.95408E-07 0.25% 
9 2 2.50979E-06 2.51490E-06 0.20% 
10 1 1.00438E-05 1.00622E-05 0.18% 
11 0.5 1.38648E-04 1.38525E-04 0.09% 
12 0.1 1.23532E-03 1.23971E-03 0.36% 
 
 
Table 6-9 Hydrogen MCNP5 versus NJOY99 microscopic incoherent cross section  
Gamma 
Group # 
Energy 
Bin Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 4.62183E-02 4.62297E-02 0.02% 
2 9 5.76170E-02 5.75353E-02 0.14% 
3 8 6.29983E-02 6.28132E-02 0.29% 
4 7 6.96547E-02 6.95146E-02 0.20% 
5 6 7.81807E-02 7.83742E-02 0.25% 
6 5 8.95164E-02 8.93816E-02 0.15% 
7 4 1.05534E-01 1.05450E-01 0.08% 
8 3 1.30377E-01 1.30810E-01 0.33% 
9 2 1.77687E-01 1.77988E-01 0.17% 
10 1 2.49288E-01 2.49738E-01 0.18% 
11 0.5 3.91225E-01 3.92565E-01 0.34% 
12 0.1 5.24300E-01 5.25375E-01 0.21% 
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Table 6-10 Hydrogen MCNP5 versus NJOY99 microscopic pair production cross section 
Gamma 
Group # 
Energy Bin 
Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 3.74025E-03 3.77851E-03 1.02% 
2 9 2.70373E-03 2.79315E-03 3.31% 
3 8 2.31837E-03 2.42670E-03 4.67% 
4 7 1.95005E-03 2.04504E-03 4.87% 
5 6 1.59786E-03 1.62819E-03 1.90% 
6 5 1.20084E-03 1.19499E-03 0.49% 
7 4 7.52261E-04 7.48357E-04 0.52% 
8 3 3.30758E-04 3.37645E-04 2.08% 
9 2 4.64079E-05 4.90613E-05 5.72% 
10 1    
11 0.5    
12 0.1    
 
 
Table 6-11 Oxygen MCNP5 versus NJOY99 microscopic total cross section  
Gamma 
Group 
# 
Energy Bin 
Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 5.31021E-01 5.32199E-01 0.22% 
2 9 5.84892E-01 5.87139E-01 0.38% 
3 8 6.13464E-01 6.15308E-01 0.30% 
4 7 6.52282E-01 6.54401E-01 0.32% 
5 6 7.06066E-01 7.08486E-01 0.34% 
6 5 7.79676E-01 7.78503E-01 0.15% 
7 4 8.87199E-01 8.86891E-01 0.03% 
8 3 1.06334E+00 1.06838E+00 0.47% 
9 2 1.42449E+00 1.42848E+00 0.28% 
10 1 1.99643E+00 2.00133E+00 0.25% 
11 0.5 3.17376E+00 3.18718E+00 0.42% 
12 0.1 5.16900E+00 5.24894E+00 1.55% 
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Table 6-12 Oxygen MCNP5 versus NJOY99 microscopic coherent cross  
Gamma 
Group 
# 
Energy Bin 
Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 1.33662E-05 1.33169E-05 0.37% 
2 9 2.34510E-05 2.33750E-05 0.32% 
3 8 3.02112E-05 3.00441E-05 0.55% 
4 7 4.02979E-05 4.01478E-05 0.37% 
5 6 5.64608E-05 5.62157E-05 0.43% 
6 5 8.49860E-05 8.46867E-05 0.35% 
7 4 1.42551E-04 1.41744E-04 0.57% 
8 3 2.88128E-04 2.86987E-04 0.40% 
9 2 9.10674E-04 9.07008E-04 0.40% 
10 1 3.63765E-03 3.62853E-03 0.25% 
11 0.5 4.86921E-02 4.86863E-02 0.01% 
12 0.1 3.72903E-01 3.75561E-01 0.71% 
 
 
Table 6-13 Oxygen MCNP5 versus NJOY99 microscopic incoherent cross section  
Gamma 
Group 
# 
Energy Bin 
Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 3.69741E-01 3.70044E-01 0.08% 
2 9 4.60928E-01 4.60544E-01 0.08% 
3 8 5.03975E-01 5.02794E-01 0.23% 
4 7 5.57223E-01 5.56428E-01 0.14% 
5 6 6.25425E-01 6.27338E-01 0.31% 
6 5 7.16099E-01 7.15436E-01 0.09% 
7 4 8.44214E-01 8.44035E-01 0.02% 
8 3 1.04263E+00 1.04698E+00 0.42% 
9 2 1.42077E+00 1.42434E+00 0.25% 
10 1 1.99253E+00 1.99743E+00 0.25% 
11 0.5 3.10977E+00 3.12266E+00 0.41% 
12 0.1 4.06360E+00 4.07110E+00 0.18% 
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Table 6-14 Oxygen MCNP5 versus NJOY99 microscopic pair production cross section 
Gamma 
Group # 
Energy Bin 
Upper 
Bound 
(MeV) 
MCNP NJOY99 
Compare 
% 
Difference 
1 20 1.61263E-01 1.62139E-01 0.54% 
2 9 1.23936E-01 1.26567E-01 2.12% 
3 8 1.09453E-01 1.12478E-01 2.76% 
4 7 9.50131E-02 9.79258E-02 3.07% 
5 6 8.05781E-02 8.10834E-02 0.63% 
6 5 6.34832E-02 6.29717E-02 0.81% 
7 4 4.28291E-02 4.26991E-02 0.30% 
8 3 2.04069E-02 2.10853E-02 3.32% 
9 2 2.75718E-03 3.17661E-03 15.21% 
10 1    
11 0.5    
12 0.1    
 
6.3. Sample problem 1: Forward case  
The first full calculation is a forward calculation that uses the beam source impinging straight 
down onto the top of the patient box.  The problem was run with both Voxel8 and MCNP5 in 
multigroup mode.  For comparison of the results, both of them captured a vertical “slice” 2D flux 
map through the center of the water box at q  	0.5	-1.  Figure 6-5 shows the resulting flux map 
for the MCNP5 calculation and Figure 6-6 shows the equivalent map for the Voxel8 calculation. 
The MCNP5 and Voxel8 maps were compared using three points maximum, minimum, and 
weighted average.  Table 6-15 gives a summary of this comparison.  The position for the 
maximum and minimum points was determined from the MCNP5 calculation.  Then the 
corresponding Voxel8 calculation location values were looked up and compared to the MCNP5 
result.  The weighted average was calculated for each map using a frequency table.  When the 
comparison point is in the useful beam area (i.e. maximum point and along beam central axis up 
to a depth 0f 25 cm) these results show good agreement between MCNP5 and Voxel8 
calculation.  Larger differences are found at the peripheries due to small quantity of scattered 
photons arriving at these locations.  These locations are not useful clinically and can be ignored.  
Reduction in the large differences can be achieved by implementing more variance reduction 
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techniques (i.e. the population control method such as geometry splitting and Russian Roulette, 
or modified sampling methods such as forced collisions).  Russian Roulette was implemented in 
the Voxel8 code but not the forced collision method.  Forced collision can be implemented at 
end of particle history.  The voxels along the ray from the end of history location to the boundary 
are determined.  Then contribution to each voxel is made based on the probability of a particle 
arriving at the voxel. 
 
 
Figure 6-5 MCNP5 flux map for forward problem (per source particle) 
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Figure 6-6 Voxel8 flux map for forward problem (per source particle) 
 
Table 6-15 Summary of Results for forward problem 
 Fluence (1/cm2) 
Value MCNP5 Voxel8 Difference% 
Maximum 
(0.75, 0.75) 
9.44794E-06 
+/- 0.403% 
9.132354E-06 
+/- 0.525% 3.40% 
Minimum 
(24.25,49.75) 
2.37421E-08 
+/- 7.63% 
2.9403903E-08 
+/- 7.57% 21.31% 
Weighted 
Average 
1.071899E-06 
+/- 2.32% 
1.114044E-06 
+/- 2.88% 3.86% 
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Figure 6-7 Normalized forward flux along CAX for measurement, MCNP5 & Voxel8 
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6.4. Sample problem 2: Adjoint case 
The second set of calculations was adjoint calculations for a simple box and for the four 
structures of interest as defined in Section 6.1: Tumor, right eye, left eye, and brain.  For each of 
these cases, a 2D map of the surface adjoint fluxes on the top surface were compared for both 
Pixel8 and MCNP5 in multigroup mode.  The following figures and table document the results: 
1. For the box region, Figure 6-8and Figure 6-9 give the resulting maps, with Table 
6-16 showing a comparison of the maximum, minimum and weighted average 
values in the map. 
2. For the tumor region, Figure 6-10 and Figure 6-11 give the resulting maps, with 
Table 6-17 showing a comparison of the maximum, minimum and weighted 
average in the map. 
3. For the right eye region, Figure 6-12 and Figure 6-13 give the resulting maps, 
with Table 6-18 showing a comparison of the maximum, minimum and weighted 
average values in the map. 
4. For the left eye region, Figure 6-14 and Figure 6-15 give the resulting maps, with 
Table 6-19 showing a comparison of the maximum, minimum and weighted 
average values in the map. 
5. For the brain region, Figure 6-16 and Figure 6-17 give the resulting maps, with 
Table 6-20 showing a comparison of the maximum, minimum and weighted 
average values in the map. 
 
These results show the following: 
1. For the simple box region adjoint multigroup MCNP5 and Pixel8 calculation 
showed excellent agreement.  The largest deviation was at the minimum value 
with a pixel location that is not clinically significant.  This large deviation is due 
to the low number of particles arriving at the pixel.  Reduction in the deviation 
can be achieved by implementing further variance reduction techniques.  The 
visible large dose pixels that appear in the Pixel8 plot are due to the adjoint 
weights becoming greater than one after scattering event.  The Pixel8 algorithm 
did not employ any population control variance reduction technique such as 
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weight window.  Implementing such variance reduction techniques will reduce 
these deviations. 
2. For the tumor region adjoint multigroup MCNP5 and Pixel8 calculation showed a 
maximum deviation of 10.39%.  The largest deviation was at the minimum value.  
Again the minimum value location is not clinically significant.  This large 
deviation is due to the low number of particles arriving at the pixel.  The deviation 
at the maximum point is attributed to structure pixilation, possible geometrical 
positioning error and coding error that we could not find at the time of dissertation 
writing.  Again the visible large dose pixels appear and they are attributed to the 
reason given above. 
3. For the right eye region adjoint multigroup MCNP5 and Pixel8 calculation 
showed a maximum deviation of 11.00%.  The largest deviation was at the 
minimum value which is at a location that is not clinically significant and due to 
the low number of particles arriving at the pixel location.  The deviation at the 
maximum point is attributed to structure pixilation, possible geometrical 
positioning error and coding error that we could not find at the time of dissertation 
writing.  Again the visible large dose pixels appear and they are attributed to the 
reason given above. 
4. For the left eye region adjoint multigroup MCNP5 and Pixel8 calculation showed 
better agreement at the maximum point within 1.00%.  The largest deviation was 
at the minimum value which is at a location that is not clinically significant and 
due to the low number of particles arriving at the pixel location.  Again the visible 
large dose pixels appear and they are attributed to the reason given above. 
5. For the complicated and large brain region adjoint multigroup MCNP5 and Pixel8 
calculation showed large deviations.  The deviations are attributed to structure 
pixilation, a discovered geometrical error and possible coding error that we could 
not find at the time of dissertation writing.  Again the visible large dose pixels 
appear and they are attributed to the reason given above. 
 
The weighted average value was computed from a generated frequency table of the 2D 
map.   
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Figure 6-8 MCNP5 surface flux map for adjoint problem: Box 
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Figure 6-9 Pixel8 surface flux map for adjoint problem: Box 
 
Table 6-16 Summary of Results for adjoint problem: Box 
 Fluence (cGy/cm2) 
Value MCNP5 Pixel8 % Difference 
Maximum 
(0.25,0.25) 
2.36865E-03 
+/- 0.297% 
2.33172E-03 
+/- 0.222% 1.57% 
Minimum 
(-24.75, 24.75) 
2.80921E-05 
+/- 5.505% 
3.46025E-05 
+/- 3.078% 20.77% 
Weighted 
Average 
2.81394E0-4 
+/- 2.503% 
2.83882E-04 
+/- 0.88% 0.88% 
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Figure 6-10 MCNP5 surface flux map for adjoint problem: Tumor 
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Figure 6-11 Pixel8 surface flux map for adjoint problem: Tumor 
 
Table 6-17 Summary of Results for adjoint problem: Tumor 
 Fluence (1/cm2) 
Value MCNP5 Pixel8 % Difference 
Maximum 
(3.75,2.75) 
3.23942E-04  
+/- 0.858% 
3.04541E-04 
+/- 2.30% 6.17% 
Minimum 
(-24.25,-24.75) 
1.84468E-5  
+/- 4.903% 
2.04679E-05  
+/- 5.770% 10.39% 
Weighted 
Average 
1.15757E-04 
+/- 2.381% 
1.12671E-04 
+/- 4.219% 2.70% 
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Figure 6-12 MCNP5 surface flux map for adjoint problem: Right eye 
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Figure 6-13 Pixel8 surface flux map for adjoint problem: Right eye 
 
Table 6-18 Summary of Results for adjoint problem: Right eye 
 Fluence (cGy/cm2) 
Value MCNP5 Pixel8 % Difference 
Maximum 
(-7.25,0.25) 
6.06000E-03 
 +/- 0.202% 
6.17760E-03 
+/- 1.617% 6.61% 
Minimum 
(23.25,-24.75) 
1.68641E-05  
+/- 9.199% 
1.88279E-05 
+/- 7.85% 11.00% 
Weighted 
Average 
3.71487E-04 
+/- 3.232% 
3.4579E-04 
+/- 4.322% 7.16% 
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Figure 6-14 MCNP5 surface flux map for adjoint problem: Left eye 
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Figure 6-15 Pixel8 surface flux map for adjoint problem: Left eye 
 
Table 6-19 Summary of Results for adjoint problem: Left eye 
 Fluence (cGy/cm2) 
Value MCNP5 Pixel8 % Difference 
Maximum 
(7.25,0.25) 
6.0381E-03 
+/- 0.201% 
6.08275E-03 
+/- 0.21% 0.74% 
Minimum 
(-24.75,24.75) 
1.70507E-05 
+/- 8.797% 
2.18755E-05 
+/- 7.990% 24.79% 
Weighted 
Average 
3.71477E-04 
3.229% 
3.45934E-04 
+/- 4.513% 7.12% 
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Figure 6-16 MCNP5 surface flux map for adjoint problem: Brain 
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Figure 6-17 Pixel8 surface flux map for adjoint problem: Brain 
Table 6-20 Summary of Results for adjoint problem: Brain 
 Adjoint Fluence (cGy/cm2) 
Value MCNP5 Pixel8 % Difference 
Maximum 
(0.25,4.25) 
1.04056E-04 
+/- 1.772% 
7.45955E-05  
+/-1.789 32.98% 
Minimum 
(-24.25,-24.75) 
1.77514E-05 
+/- 4.193% 
1.18301E-05 
+/- 3.732% 40.03% 
Weighted 
Average 
5.81601E-05 
2.634% 
4.86977E-05 
+/- 3.495% 17.71% 
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6.5. Sample problem 3: Hybrid forward/adjoint case 
The final case tested the hybrid forward/adjoint methodology by comparing the dose in the 
four structures computed calculated using: 
• A single forward MCNP5 calculation which—instead of creating the flux maps described 
in Section 6.4—used an F4 tally and the 12-group dose response functions to comp 
compute the dose rate in each of the four structures. 
• A hybrid forward/adjoint surface integration using the surface adjoint flux maps from the 
four adjoint calculations described in Section 6.3.  These surface dose sensitivity values 
were folded into the surface forward fluxes by position, direction, and energy group to 
also estimate the structure dose rates. 
 
These two ways of computing the structure doses are compared in Table 6-21 through Table 
6-24 for each of the four structures used in the sample problems.  The MCNP5 and Pixel8 results 
show an agreement between 4.8955% - 8.181%.  The deviation is due to region of interest 
pixilation and possible geometrical positioning errors introduced during the adjoint calculation. 
 
Table 6-21 Summary of hybrid forward/adjoint results: Tumor 
Gamma 
Group # 
Energy bin 
upper bound 
(MeV) 
Response (cGy) Relative error (%) 
1 0.010 0.00000E+00 0.00% 
2 0.100 3.42794E-14 0.72% 
3 0.500 2.96674E-13 0.41% 
4 1.000 3.92613E-13 0.46% 
5 2.000 7.61435E-13 0.40% 
6 3.000 5.75613E-13 0.52% 
7 4.000 4.03112E-13 0.67% 
8 5.000 2.51975E-13 0.91% 
9 6.000 6.80292E-14 1.86% 
 
Total 2.78373E-12 0.22% 
 
Pixel8 results 2.592670E-12 0.800% 
 
Difference 7.107%  
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Table 6-22 Summary of hybrid forward/adjoint results: Right eye 
Gamma 
Group # 
Energy bin 
upper bound 
(MeV) 
Response (cGy) Relative error (%) 
1 0.010 0.00000E+00 0.00% 
2 0.100 2.69256E-14 0.36% 
3 0.500 2.38840E-13 0.20% 
4 1.000 1.67970E-13 0.27% 
5 2.000 2.42108E-13 0.27% 
6 3.000 1.61357E-13 0.37% 
7 4.000 1.06317E-13 0.50% 
8 5.000 6.47456E-14 0.69% 
9 6.000 1.73201E-14 1.41% 
 
Total MCNP5 1.02558E-12 0.13% 
 
Pixel8 results 1.109128E-12 0.398% 
 
Difference 7.828%  
 
 
Table 6-23 Summary of hybrid forward/adjoint results: Left eye 
Gamma 
Group # 
Energy bin 
upper bound 
(MeV) 
Response (cGy) Relative error (%) 
1 0.010 0.00000E+00 0.00% 
2 0.100 2.69212E-14 0.36% 
3 0.500 2.38445E-13 0.20% 
4 1.000 1.68483E-13 0.27% 
5 2.000 2.41317E-13 0.27% 
6 3.000 1.60905E-13 0.37% 
7 4.000 1.07009E-13 0.50% 
8 5.000 6.47643E-14 0.69% 
9 6.000 1.72584E-14 1.41% 
 
Total MCNP5 1.02510E-12 0.13% 
 
Pixel8 results 9.445316E-13 0.398% 
 
Difference 8.181%  
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Table 6-24 Summary of hybrid forward/adjoint results: Brain 
Gamma 
Group # 
Energy bin 
upper bound 
(MeV) 
Response (cGy) Relative error (%) 
1 0.010 0.00000E+00 0.00% 
2 0.100 1.79715E-14 0.13% 
3 0.500 1.07281E-13 0.08% 
4 1.000 7.50288E-14 0.10% 
5 2.000 1.19812E-13 0.09% 
6 3.000 8.56401E-14 0.13% 
7 4.000 6.00521E-14 0.16% 
8 5.000 3.73172E-14 0.22% 
9 6.000 1.04133E-14 0.45% 
 
Total MCNP5 5.13516E-13 0.05% 
 
Pixel8 results 4.889777E-13 0.079% 
 
 % Difference 4.895%  
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  Chapter 7
Conclusions and future work 
7.1. Conclusions 
This project has successfully developed a new Monte Carlo code for use in radiation therapy 
treatment planning with the following characteristics: 
1. Capability of performing either forward or adjoint photon transport calculations; 
2. Implementation of fictitious scattering as a more efficient utilization of computer 
time when used with a voxelized geometry description; 
3. Implementation of a hybrid forward/adjoint calculation scheme to allow 
precalculated adjoint calculations of patient organ surface dose response functions 
to be coupled with fast-running forward transport of source surface fluxes from 
photon sources. 
The code has been successfully tested versus MCNP5 in the calculation of a simulated water-
based patient/source configuration.  The results show that the method is working properly. 
7.2. Future work 
This project represents a proof-of-principle implementation to demonstrate the viability of 
the innovations included in the code.  In order for this work to reach clinical treatment planning 
application, more work will be needed in the areas of: 
1. Debug the code to minimize structure pixelating errors and eliminate structure 
positioning errors. 
2. Optimization of the code to minimize analysis time. 
3. Testing of the code against multi-region problems. 
4. Testing of the optimized code against a wider range of clinical problems to 
validate the accuracy, efficacy, and efficiency of the approach versus current 
methods in clinical use. 
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Appendix A 
Cross section and Transport data generation 
A.1. Data needed for Monte Carlo transport 
When transporting a particle in a medium several important basic parameters about the 
particle state are needed to chart the particle random walk through the medium correctly. 
Examples of such particle state parameters are:  
1. Particle initial position, direction and energy,  
2. Type of interactions occurring during the random walk to determine the scattered 
particle energy and new direction. 
As a result accurate knowledge of the particle physics and ability to model it probabilistically 
is essential to make accurate decision during the particle random walk. It is common to use an 
input data file to provide all necessary particle data to chart the random walk accurately. 
On the first hand, our research interested is beams of photon particles used in radiotherapy, 
hence particles that are in the mega electron volt energy range, we will concentrate only on the 
most dominant photon interactions in that energy range. The photon interactions in this energy 
are mainly scattering events (such as Compton, Rayleigh scattering and pair production). 
Secondly, our research interested is focused on finding the adjoint solution for the Boltzmann 
transport equation.  Solving such equation requires the use of multi-group cross section data. 
“NJOY99” code system is a software package that can generate multi-group cross sections from 
an ENDF file. “NJOY99” is a system of codes that was developed at “Los Alamos national lab” 
and is provided by “Radiation Information Safety Center” (RISC) group at Oakridge, Tennessee. 
“NJOY99” code system can produce multi-group cross section data needed to transport particles 
in the forward and adjoint mode for each energy group in the problem materials. The photon 
interaction cross sections generated by “NJOY99” is: 
1. Scattering cross sections (e.g., Coherent, Incoherent and Pair production). 
2. Scattering heat cross sections (used to predict Kerma / Absorbed dose for all the 
scattering interaction mentioned above). 
3. Total cross section. 
4. Total heat cross section (used to predict Kerma / Absorbed dose). 
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5. Group to group scattering cross sections for all interactions mention above. 
6. Distribution of Group to group cosine of scattering angle for all interactions above. 
 
The cross sections produced by “NJOY99” code system for any element in question 
(provided that initial input parameters are given) are microscopic and need to be post processed. 
I a code was developed that will process the “NJOY99” output data file and produce data in a 
format useful for particle transport. 
A.2. General flow of problem parameter specification 
To prepare a problem specific input deck with cross sections and transport data useful for 
transport problems three basic parameters needs to be specified.  These parameters are the 
problem elemental components, involved particle energy group structure and the particles energy 
distribution (photon source energy spectrum).  Once these parameters are specified cross sections 
and transport data can be generated.  The final component of this data is dependent on the 
problem mode.  In the forward mode we need to specify several forward source (beam) 
parameters while in the adjoint mode we need to specify adjoint source parameters. 
This general process flow is illustrated in Figure A-1.  We start the process by creating 
problem material map.  The result of this step is a list of elemental components present in the 
problem.  We then need to specify the energy group structure of the problem particles.  This 
energy group structure can be either a user defined structure or selected from “NJOY99” built-in 
group structure.  Then we specify the problem particles energy distribution (photon source 
energy spectrum). 
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Figure A-1 General data generation flow 
 
These parameters are feed into the cross section and transport data generator.  The result is an 
“ASII” file that contains the problem specific cross sections and transport data for both modes 
(i.e., forward and adjoint).  The following is a brief description of each component. 
 
A.3. Material Map Generator 
The main interface allows the user to either go to a patient database or physics data mode.  
Selecting the patient database invokes the “Material map generator” module. The “Material 
map generator” module enables the user to either import CT axial images or create a phantom 
data set as illustrated in Figure A-2.  The result of the “Material map generator” is a set of data 
files in matrix (table) format. Each file represents a Z coordinate level.  The file data points are 
integers that represent material that resides in that voxel.  The matrix row represents X 
coordinate level and matrix column represents Y coordinate level.  A summary of the data files 
CT numbers tally is also produced to be used when generating cross section data. 
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Figure A-2 Material map generator 
 
A.4. Energy group structure generator 
Specification of source particles energy structure is needed and used in the following 
modules: 
a. Cross section and transport data generation. 
b. Source photon spectrum generation.  
c. Forward and adjoint Monte Carlo transport. 
 
Energy structure can be either designed or read from an existing list of files. The existing 
structure files are NJOY99 internal energy structures. The result of this module is an “ASCII” 
file that lists the energy structure boundaries. This file is used in the NJOY99 interface to 
produce a batch file that run “NJOY99”.  Figure A-3 is illustrates this process. 
 
 
Figure A-3 Energy group structure generator  
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A.5. Source spectrum energy structure adjuster 
Once the group structure is defined the photon source energy spectrum can be selected. The 
user selects a photon spectrum from published data.  This is illustrated in Figure A-4.  Then the 
code adjusts the spectrum energy bins to match the selected group structure energy bins.  As a 
result an “ASCII” file that will contain information about our: 
a) Choice of photon spectrum,  
b) Number of photon spectrum energy bins after adjustment 
c) CDF for each energy bin after adjustment.  
 
 
Figure A-4 Source spectrum energy structure adjuster 
 
Once all these initial problem parameters are specified the cross section and transport data 
generation steps starts by initiating the “NJOY99” interface. 
 
A.6. Microscopic Cross section data generation using “NJOY99” code system 
To generate the microscopic group cross sections for problem materials we need to run 
“NJOY99” code system.  To run “NJOY99” we need to specify an energy group structure and 
provide the code system an evaluated nuclear data file “ENDF”.  The energy group structure can 
be either a user-specified energy structure or a built-in energy structure.  A user interface was 
developed to aid in viewing built-in, and design new energy group structure.  The “ENDF” file 
used is the “ENDF/B-VI” for photo-atomic interactions. This file is available in public domain 
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from the “International Atomic Energy Agency” nuclear data services branch.  A user interface 
was designed to assist in running the “NJOY99” code system.  Figure A-5 describes the rest of 
the parameters needed to generate the microscopic group cross section by the “NJOY99” code 
system.  The result of running this interface is an “ASCII” file that contains all available 
microscopic photon cross sections for the specified elements. 
 
Figure A-5 "NJOY99" interface that generate elemental group microscopic cross section 
 
A.7. Generation of transport data 
Once “NJOY99” output file is generated we can generation of transport data. A special 
interface was built to facilitate this task. In this interface the user makes the following choices: 
a) “NJOY99” output file to use. 
b) Select problem material as: 
I. Element 
II. Tissue 
The result of is the needed data to perform forward and adjoint Monte Carlo transport.  The 
process is illustrated in Figure A-6. 
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Figure A-6 Transport data generation 
 
A.7.1 Total macroscopic cross section 
“NJOY99” generates different interaction reactions cross section data in units of dC=g. 
The following is a procedure to convert the generated data to appropriate units of d 
<g: 
1. A single isotope atomic density "#°ê³´³$® is the number of atoms in a unit volume of the 
isotope and is computed from: 
"#°ê³´³$® 	  	
"&==%[ d -1gþ&==%[ 	d 12./g
	Ú	íH ¹+21012./ » 	 "&==%[ Ú 	íHþ&==%[ 	¹
+210-1 »			 
2. For a material made of several isotopes ,  1, ⋯ , í the ,& isotope atomic density 
d"#°ê³´³$®g& with density contribution K"&==%[P& d <'g to the material density 
"[C& d <'g is: 
d"°ê³´³$®g& 	 	
K"&==%[P& d -1gKþ&==%[P& 	d 12./g
	Ú 	íH ¹+21012./ »		
d"°ê³´³$®g& 	 ¢
"&==%[þ&==%[£& 	Ú 	íH ¹
+210-1 »	
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For a material with known isotope weight fraction contribution K?&==%[P&the isotope i density 
K"&==%[P& in the material is computed from K"&==%[ 	 	 ?&==%[ Ú 	"[C&P& isotope , atomic 
density is computed by substituting K?&==%[ Ú 	"[C&P& for isotope i density "&==%[ in the 
above equation: 
d"#°ê³´³$®g&  		 ¢
?&==%[þ&==%[£& Ú 	"[C& 	Ú 	íH ¹
+210-1 » 
3. For a certain reaction type a single isotope macroscopic cross section ΣI	½%[&==%[  in units 
of d 
<g from the same microscopic cross section )I	½%[&==%[  in units of dC=g is 
computed as follow: 
ΣI	½%[&==%[ 		 	"#°ê³´³$® 	¹+210-1 » 	Ú 	)I	½%[&==%[ ¹*5+21» Ú 10X 	¢ -1

*5£	
ΣI	½%[&==%[ 		 	"&==%[ Ú 	íHþ&==%[ 	¹
+210-1 » 	Ú 	)I	½%[&==%[ ¹*5+21» Ú 10X 	¢ -1

*5£	
	ΣI	½%[&==%[ 	 	 ù)I	½%[
&==%[ 	Ú 	íH	Ú 	"&==%[ Ú 	10X		þ&==%[ 	 ú	
ΣI	½%[&==%[ 	 	)I	½%[&==%[ Ú ¢		"&==%[ 			þ&==%[ 	 £ 	Ú	íH Ú 	10X ¹
1-1» 
It is customary to compute the macroscopic cross section in a unit of d<* g to eliminate the 
density effect (mass cross section). The above equation becomes: 
ΣI	½%[&==%[		"&==%[ 		 	 ù
)I	½%[&==%[þ&==%[ 	 ú 	Ú	íH Ú 	10X 	¢
-1 £ 
4. For a material composed of several isotopes ,  1, ⋯ , í and K?&==%[P& is the weight 
fraction contribution of isotope , to the material density, the density independent 
macroscopic cross section is: 
ΣI	½%[[C&		"[C& 		 	K?&==%[P& Ú ù
ΣI	½%[&==%[		"&==%[ ú& 	¢
-1 £

&	
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ΣI	½%[[C&		"[C& 	 	K?&==%[P& 	Ú ù
)I	½%[&==%[þ&==%[ 	 ú& Ú íH Ú 10
X
&	

	¢-1 £	
Multiply by 		"[C&: 
ΣI	½%[[C& 	 	 íH Ú 10X ÚdK?&==%[P& 	Ú 		"[C&g Ú ù)I	½%[
&==%[
þ&==%[ 	 ú&

&	

	¹ 1-1» 
Since K"&==%[P& 	 	 K?&==%[P& 	Ú 		"[C& in the material then: 
ΣI	½%[[C& 		 	 íH Ú 10X Úù"&==%[ Ú )I	½%[
&==%[
þ&==%[ 	 ú& ¹
1-1»

&	

 
 
In summary: 
1. The mass macroscopic cross section (per unit density): 
a. Isotope ,: 
ùI	½%[&==%[		"&==%[ ú& 	 ù
)I	½%[&==%[þ&==%[ 	 ú& Ú íH Ú 10
X ¢-1 £ (ANSI/ANS-6.1.1) 
b. Material with K?&==%[P& weight fraction for isotope , : 
ΣI	½%[[C&		"[C& 		 	K?&==%[P& 	Ú ù
ΣI	½%[&==%[		"&==%[ú&

&	

	¢-1 £ (2) 
2. The macroscopic cross section (per cm): 
a. Isotope , : 
KΣI	½%[&==%[ P&  ¢σI	½%[&==%[ Ú "&==%[þ&==%[£& Ú íH Ú 10
X ¹ 1-1» 
b. Material with ?& weight fraction of isotope , : 
ΣI	½%[[C& 		 	K?&==%[P& Ú "[C& 	Ú ùΣI	½%[
&==%[
		"&==%[ ú&

&	

	¹ 1-1»  
ΣI	½%[[C& 		 "[C& Ú íH Ú 10X
Ú¢)I	½%[&==%[ Ú ?&==%[þ&==%[ 	£&

&	

	¹ 1-1» (3) 
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A.7.2 Total heat macroscopic cross section 
NJOY99 generates different heat reactions cross section data in units of /ó 9 *5. 
According to the NJOY99 manual the heat cross section is the product of the particular 
microscopic cross section and the average energy released as a result of the interaction. 
Therefore the above unit is thought of as d [ô		C=&&==g The following is a procedure to convert 
this generated data to appropriate units of dð[ô<* g 	5'		-o 9 -1: 
1. For a certain reaction type we can compute a heat macroscopic cross section for a single 
isotope Σ,[	&==%[  in units of d[ô<g from the same microscopic cross section ),[&==%[ in 
units of /ó 9 *5 is computed as follow: 
Σ,[&==%[  	"#°ê³´³$® ¹+210-1 » 	Ú 	),[&==%[ ¹/ó 9 *5+21 » Ú 10X 	¢ -1

*5£	
,[&==%[  	"&==%[ Ú 	íHþ&==%[ 	¹
+210-1 » 	Ú 	),[&==%[ ¹/ó 9 *5+21 » Ú 10X 	¢ -1

*5£	
	,[&==%[  	 ù),[
&==%[ 	Ú 	íH	Ú 	"&==%[ Ú 	10X		þ&==%[ 	 ú	
,[&==%[  	 ¢		"&==%[ Ú íH Ú 	10X			þ&==%[ 	 £ 	Ú 	),[&==%[ ¹
/ó-1»	
Converting the units to dð[ô< g by multiplying by d
Ú
W-ð[ô[ô g we get:  
Σ,[&==%[ 	 	 ¢		"&==%[ Ú íH Ú	10W			þ&==%[ 	 £ 	Ú 	),[&==%[ ¹
/ó-1 »	
it is customary to report the heat macroscopic cross section in a unit of dð[ô<* g to eliminate 
the density effect (mass cross section). This is done by dividing above equation by the density: 
Σ,[&==%[		"&==%[ 	 ¢
íH Ú	10Wþ&==%[ 	 £ Ú 	),[&==%[ ¢
/ó 9 -1 £ 
2. For a material composed of several isotopes ,  1, ⋯ , í and K?&==%[P& is isotope , 
weight fraction contribution to the material density, therefore; the density independent 
macroscopic cross section is: 
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Σ,[[C&		"[C& 	K?&==%[P& Ú ¢
Σ,[&==%[		"&==%[£& 	¢
/ó 9 -1 £

&	

		
Substitute the isotope mass heat cross section in this equation we get: 
,[[C&		"[C& 	K?&==%[P& Ú ¢
),[&==%[þ&==%[ 	£& Ú íH Ú	10
W ¢/ó 9 -1 £

&	

		
,[[C&		"[C& 	 íH Ú	10Wù
?&==%[ Ú ),[&==%[þ&==%[ 	 ú& ¢
/ó 9 -1 £

&	

	 
3. To convert dð[ô<* g to dð[ô< g we multiply the equation by 		"[C& to get: 
,[[C& 	 íH Ú	10W ÚK?&==%[P& Ú 		"[C& Ú ¢),[
&==%[
þ&==%[ 	£& ¹
/ó-1 »

&	

		
Since K"&==%[P& 	 	 K?&==%[P& 	Ú 		"[C& then: 
,[[C& 	 	 íH Ú	10W Úù"&==%[ Ú ),[
&==%[
þ&==%[ 	 ú& ¹
/ó-1 »

&	

	 
4. Assuming that the energy released in an interaction is deposited in a voxel with weight 
¨©+.=[ .The energy released in a voxel is: 
F5/*o	ª/./0/'.=[ 			 ,[[C&¨©+.=[ ¹
/ó 9 -1»	
for a voxel with volume ó.=[ and density ".=[ the voxel weight is: 
¨©+.=[ 	 	".=[ Ú ó.=[	
the energy released in a voxel per interaction become: 
F5/*o	ª/./0/'.=[ 			 Σ,[[C&".=[ Ú ó.=[ ¹
/ó 9 -1»	
substitute the last equation in the step above in we get: 
F5/*o	ª/./0/'.=[ 			 íH Ú	10W".=[ Ú ó.=[ Úù
"&==%[ Ú ),[&==%[þ&==%[	 ú& ¹
/ó 9 -1»

&	

 
 
5. To convert d ð[ô<g to d<½<g we compute the ¹ <½ð[ô / » factor: 
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1000	p 	Ú 	1.602 Ú 10

n24.//ó 	Ú	 on24./ p/
	Ú 	100	-oo 	 		1.602 Ú 101 	 -o/ó /  
The absorbed dose in a voxel ò.=[ for each interaction: 
ò.=[,5+/*-+,25  	íH Ú 	1.602 Ú 10
1
".=[ Ú ó.=[ Úù
?&==%[ Ú ),[&==%[þ&==%[	 ú& ¹
-o-1 »

&	

 
 
6. For photon fluence of a  d%C&<[<* g the reaction rate ª2  for any type of interaction in a 
volume (number of interaction) is: 
ª2 	 	Σ	
therefore, absorbed dose in a voxel from all particle interaction: 
ò.=[ 	 	 ò.=[,5+/*-+,25 	¹-o-1 » Ú 	 ¹)*+,-./0-1 »	
ò.=[ 	 	íH Ú 	 Ú 	1.602 Ú 101".=[ Ú ó.=[ Úù
?&==%[ Ú ),[&==%[þ&==%[	 ú& -o

&	

	
The absorbed dose per photon fluence is: 
ò.=[	  	íH Ú 1.602 Ú 10
1
".=[ Ú ó.=[ Úù
?&==%[ Ú ),[&==%[þ&==%[	 ú& -o 9 -1

&	

 
 
 
In summary: 
1. The mass macroscopic heat cross section (per unit density): 
a. Isotope ,: 
¢ Σ,[&==%[		"&==%[£& 	¢
/ó 9 -1 £ 	 	¢),[
&==%[
þ&==%[ 	£& Ú	íH Ú	10
W	¢/ó 9 -1 £ 
b. Material with K?&==%[P& weight fraction for isotope , : 
Σ,[[C&		"[C& 	¢
/ó 9 -1 £ 	 	K?&==%[P& Ú ¢ Σ,[
&==%[
		"&==%[£& ¢
/ó 9 -1 £

&	

	 
2. The macroscopic heat cross section dð[ô< g: 
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a. Isotope , : 
¢Σ,[&==%[ ¹/ó-1 »£& 		 	 ¢),[
&==%[ Ú 		"&==%[ 			þ&==%[ 	 £& 	Ú 	íH Ú	10
W	¹/ó-1 » 
b. Material with ?& weight fraction of isotope , : 
Σ,[[C& ¹/ó-1 » 			K?&==%[P& Ú "[C& Ú ¢Σ,[
&==%[
"&==%[ 	£& ¹
/ó-1 »

&	

		
Σ,[[C& ¹/ó-1 »  "[C& Ú íH Ú	10W Úù),[
&==%[ Ú ?&==%[þ&==%[	 ú&

&	

¹/ó-1 »	 
c. Absorbed dose in a voxel from photon fluence of a  d%C&<[<* g : 
ò.=[	  	íH Ú 1.602 Ú 10
1
".=[ Ú ó.=[ Úù
?&==%[ Ú ),[&==%[þ&==%[ 	 ú& -o 9 -1

&	

 
 
A.8. Scattering cross sections and its probability 
The scattering cross sections are defined using the following two independent variables 
(hence double differential): 
a) ENERGY – The Energy group of the Incident photon to the scattered photon. 
b) ANGULAR - The scattering angle for the scattered photon (the result is angular 
distribution). 
“NJOY99” generates three microscopic scattering cross sections: 
a) Coherent Scattering – Raleigh Scattering: 
There is no energy loss occur during this interaction. The incident photon emerges with the 
same energy but traveling in a different direction. The differential scattering cross section at 
location *L is denoted by )=&[C[K*L, Ω′ ∙ Ω, E → FP 
b) Incoherent Scattering – Compton Scattering: 
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The incident photon emerges from the reaction in a different direction. The photon loses 
some energy in the interaction. The differential cross section at location r is denoted by 
)3<=&[C[K*L, Ω′ ∙ Ω, E → FP 
c) Pair Production is considered a scattering interaction:  
Therefore, in general (for all energy and scattering angles) the overall scattering cross section 
is defined to be: 
)Z<[C& 	 	)=&[C[ 	# 	)3<=&[C[ 	# 	)4&C	4C=\><&= 
Therefore, the individual contribution from each reaction to the overall scattering cross 
section: 
ý2©/*/5+	  	 )=&[C[)Z<[C& 
%5-2©/*/5+	 	)3<=&[C[)Z<[C&  
º,*	º*2'4-+,25	 	)4&C	4C=\><&=)Z<[C&  
We can convert this cross section to macroscopic cross section using the same method used 
describe to generate macroscopic total cross section from microscopic cross section.  This 
scattering cross section: 
ΣZ<[C&*, F 	 describe the probability of scattering per unit path length È 
<æ 
In a scattering event, the incident photon will change both direction of motion and energy. 
The quantity that will describe the state of the scattered photon is called the differential cross 
section.  The energy distribution of photon emerging from a scattering reaction is given by a 
macroscopic differential scattering cross section ΣZ<[C&F → F, where 
 
ΣZ<[C&F → F'F	characterizes the probability that a photon with an 
initial energy F5will scatter into 'F around	F. 
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The macroscopic scattering cross section is related to the probability that a photon with initial 
energy F will suffer a collision regardless of final energy F5 , then the integral of the macroscopic 
differential scattering cross section, )Z<[C&F → Fover all final energies F5  is the total 
scattering cross section: 
ΣZ<[C&F 	 	¤ ΣZ<[C&F → F'FVW
 
the dimension of this differential cross section is È <*><[> 	/óæ. We define the probability 
that a photon with initial energy F5will scatter into 'F aroundF is given by: 
)F → F'F	  	 Éè6µ´´®7°KT→TPÉè6µ´´®7°T 'F  
this is the probability density function in È 
ð[ôæ. The microscopic differential scattering cross 
section is defined as: 
ΣZ<[C&F → F 	 	ΣZ<[C&F 	Ú 	)F → F
 
The angular distribution for photon emerging from a scattering reaction is given by a 
microscopic differential cross section, ΣZ<[C&KΩM → ΩMP, where 
ΣZ<[C&KΩM → ΩMP Characterizes the probability that a photon with an initial angle ΩM ` 
will scatter into 'ΩM around ΩM. 
The integral of the microscopic differential scattering cross section, ΣZ<[C&KΩM → ΩMP, 
over all final directions Ω5  is the scattering cross section: 
ΣZ<[C&F  ¤ ΣZ<[C&KF, ΩM → ΩMP'RSVW
 
the dimension of this differential cross section is È <*><[> 	Q/+/*',5æ. We define the 
probability that a photon with initial directions Ω will scatter into 'Ω5  around Ω5  is given by: 
)KΩM → ΩMP'RS 	 	 ΣZ<[C&KΩM → ΩMPΣZ<[C&F 'RS
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this is the probability density function in [steradian -1]. The macroscopic differential 
scattering cross section is defined as: 
ΣZ<[C&KF, ΩM → ΩMP 	 	ΣZ<[C&F	)KΩM → ΩMP	
 
Since the macroscopic differential cross section can depend on: 
1. Photon Energy 
2. Target nuclide 
3. The initial direction Ω 
4. The final direction Ω 
Note that the dependence on the initial and final direction is rare, but the dependence is 
stronger on the angle  between the initial and final direction, hence theΩ ∙ Ω5 . Since that the 
direction vector is a unit vector therefore if we define: 
μW 	 	ΩM ∙ ΩM 	 	-20
 
Hence  
ΣZ<[C&KF, ΩM → ΩMP  ΣZ<[C&KF, ΩM ∙ ΩMP 	 	 ΣZ<[C&F, μW	
 
We can define  
'R	  	0,5	'	'	 	9'-20'	  	9'W'
 
therefore 
ΣZ<[C&F 	 U 'U ΣZ<[C&KF, ΩM → ΩMP'ΩMYW
Y
W
 
ΣZ<[C&F 	 U 'U ΣZ<[C&KF, ΩM ∙ ΩMP0,5'YW
Y
W
 
ΣZ<[C&F 	 U 'U ΣZ<[C&F, W'W«
.W
.W
Y
W
 
ΣZ<[C&F 	 2bU ΣZ<[C&F, W'W«
.W
.W
 
For the purpose of our code we need to generate the total group scattering cross section. This 
value is generated using the following equation: 
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ΣZ<[C&F 	 	Σ=&[C[F 	#	Σ3<=&[C[F 	#	Σ4&C	4C=\><&=F 
Further, the group to group macroscopic scattering cross section is computed from the 
microscopic cross section data generated by “NJOY99” using the same method describe to 
generate total macroscopic cross section. For the purpose of our problem we used the zero order 
of the Legendre polynomial to be our cross section. 
A.9. Forward scattering probability 
The forward scattering probability is derived from the total cross and forward scattering cross 
section. Total cross section is the sum of absorption and scattering cross section. The forward 
probability of scattering for a group is the result of dividing the forward scattering cross section 
by the total cross section as shown: 
Q-++/*,5	º*2,.,+o=CüC\, 		ΣZ<=CüC\,Σ=,  
The result is a number between 0 and 1. When a random number is drawn and the value is 
between 0 and the scattering probability the type of interaction occurring is downward scattering 
interaction. If the random number drawn is above the scattering probability the occurring 
interaction is absorption  
 
A.10. Adjoint scattering probability 
For the adjoint formalism, the group to group scattering cross section data need to be 
arranged. The data for the same final group is collected and arranged then a new adjoint group to 
group cross is computed. This cross section is simply for the same final group is the sum of all 
individual group to group scattering cross section as shown: 
ΣZ<\8=&,	 	 	  ΣZ<	,			→

	


	 	

 
The adjoint scattering probability is derived from the total cross and adjoint scattering cross 
section. Total cross section is the sum of absorption and scattering cross section. The adjoint 
probability of scattering for a group is the result of dividing the adjoint scattering cross section 
by the total cross section as shown: 
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Q-++/*,5	º*2,.,+o\8=&, 		ΣZ<\8=&,Σ=,  
For this ratio the result might not be a number between 0 and 1. When a random number is 
drawn and the value is between 0 and the adjoint scattering probability the type of interaction 
occurring is upward scattering interaction. If the random number drawn is above the scattering 
probability the occurring interaction is absorption. 
 
A.11. Group to group scattering probability 
The group to group scattering probability is generated from the: 
1. The group total scattering cross section; 
2. The group to group scattering cross section. 
1. Forward group to group scattering probability 
The forward group to group scattering probability is computed by dividing the group to 
group scattering cross section by the group total scattering cross section as shown below: 
*24)	+2	*24)	0-++/*,5	º*2,.,+o;=CüC\, 		 ΣZ<,→ΣZ<=CüC\, 
The ratios produce is then used to create a CDF. For the forward input file the first entry of 
the CDF data point is for the lowest down to energy group and the last data point is for the 
current energy group.  
 
A.12. Adjoint group to group scattering probability 
Then adjoint group to group scattering probability is computed by dividing the group to 
group scattering cross section by the newly computed above adjoint group to group scattering 
cross section as shown: 
*24)	+2	*24)	0-++/*,5	º*2,.,+oH\8=&, 		 ΣZ<,→ΣZ<\8=&,	 
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The ratios produce is then used to create a CDF. For the adjoint input file the first entry of the 
CDF data point is for the current energy group and the last data point is for the energy highest 
up scatter group. 
 
A.13. Group to group cosine of scattering angle 
“NJOY99” produce group to group cosine scattering angle cross sections. This data is 
presented by “NJOY99” as a Legendre polynomial coefficient. The maximum order of the 
polynomial coefficient is specified by the user as part of “NJOY99” code system needed input 
parameters. The resultant data need to be processed to be used in particle transport. It is well 
known in the literature that presentation of cross section as Legendre polynomial coefficient can 
cause the cross section to be negative for polynomials with coefficient order higher than 1. The 
negative cross section does not make any physical sense and can cause the computed 
probabilities to be negative. 
For cross sections presented by Legendre polynomial with polynomial order one or higher 
codes such as “MORSE” and “KENO” eliminates the negative cross section problem by 
computing the average cosine of the scattering angle using the zero and first Legendre 
polynomial coefficient as follow: 
̅ →   	ΣZ<4
→

ΣZ<4W→  
This value gets tabulated for each  →  interaction.  
“Morse-SGC NUREG-CR-200” document describe the method we used to generate 
scattering cosine scattering angles and their corresponding probability.  Using this method for all 
the possible group to group scattering five possible cosine of scattering angles and their 
corresponding probability was generated and tabulated. 
For our problem I used both methods.  The final code version uses the “Morse-SGC 
NUREG-CR-200” tabulated values. 
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Appendix B  
Pixel8/Voxel8 input deck description 
B.1. Type of cross sections generated and used 
In this thesis the interaction types are reduced to absorption and scattering cross sections 
only. The absorption cross section is the physical absorption interaction while the scattering 
cross section is the sum of the physical coherent, incoherent and pair production interactions. 
The generated transport cross section data is arranged by groups. For each group we generate a 
probability of absorption and of scatter, heat cross section for each interaction as well as total 
cross section and heat cross section. 
The designed code has two main programs that represent two problem mode: 
1. Forward Monte Carlo method transport 
2. Adjoint Monte Carlo transport. 
The “transport data” file used is dependent on the problem mode.  The input data deck name 
for each mode is: 
1. Forward mode: “ForwardFicMC.in” 
2. Adjoint mode: “AdjointFicMC.in” 
3. Folder mode: “Folder.in”.  this file built from a the files specified in bullet 1 and 2. 
B.2. General description of input files 
The “transport data” file follows a general format. In general the file consists of eight major 
sections.  These sections have the following general description: 
1. Section 1: Problem information and needed Monte Carlo parameters. 
2. Section 2: Source spectrum description. 
3. Section 3: Phantom-Patient Information. 
4. Section 4: Source location and emission methods. 
5. Section 5: Problem material information. 
6. Section 6: Cross sections and transport data for each energy group & material. 
7. Section 7: Group to group scattering probabilities for each problem material. 
8. Section 8: Group to group scattering angles for each problem material. 
116 
 
B.3. Forward Monte Carlo with / without Fictitious scattering input deck 
The forward Monte Carlo input deck contains the following problem specific information: 
1. Section 1: This section has general problem information and needed Monte Carlo 
parameters.  Image of this data is shown in Figure B-1. The data read from this section is 
used to setup proper problem directories and turn proper program flags. The following is 
description of each item: 
a. Problem Type. The available are: 
i. Forward where it can be: 
1. Spectrum Percent Depth Dose. 
2. Group Percent Depth Dose. 
3. Beam Simulation / Computation. 
b. Number particles to run – number of histories. 
c. Particle tracks: 
i.  Flag. 
ii. Number of tracks per track file. 
iii. Number of tracks used to plot. 
d. Particle history: 
i. Flag. 
ii. At what run to start writing particle history. 
iii. At what run to stop writing particle history. 
e. CAX percent depth dose compare flag. 
f. Source phantom entrance plot: 
i. Flag. 
ii. Number of points to plot. 
g. When to annunciate on the screen the random walk being process.  This serves as 
a Monte Carlo progress indicator. 
h. Write trouble shooting file flag. 
i. Russian Roulette parameters: 
i. Particle weight cut-off. 
ii. Particle Survival Probability 
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Figure B-1 Input file view of section 1 data 
 
2. Section 2: Source information as shown in Figure B-2.  
 
Figure B-2 Input file view of section 2 data 
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The information is: 
a. Energy group structure: 
i. Name 
ii. Number of groups 
iii. Energy bins upper limit (tabulated in rows with a given number of entries 
per row). 
b. Source photon spectrum: 
i. File name. 
ii.  Number of source spectrum points. 
iii. Source spectrums bin frequencies (tabulated in rows with a given number 
of entries per row). 
iv. Source spectrums bin CDF (tabulated in rows with a given number of 
entries per row). 
v. Source spectrums selection array information and it values as shown in 
Figure B-3: 
1. Number of entries. 
2. Number of entries per each line of search array data. 
3. Search array data in rows. 
 
 
Figure B-3 Input file view of photon spectrum search array 
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c. The standard reference beam data information: 
i. Name of standard beam. 
ii. Number of points in the standard reference beam data. 
iii. Standard reference beam data in rows. 
 
As a result of processing this section the following data is read to assist in the particle 
random walk decisions: 
i. Then number of spectrum groups. 
ii. The number of search array points (normally multiple of 1000). 
iii. The photon spectrum CDF as one dimensional array. 
iv. The photon spectrum search array values as one dimensional array. 
The search array is used to speed up the search for the particle initial group. In doing this we 
eliminate the need to look through the entire array every time we start a new history.  The 
following is description of how the search array is used during particle random walk: 
i. A random number is drawn. 
ii. The random number is converted to an integer by multiplying it with search array 
number of points to produce a search array index (e.g., between 1and 1000 for array 
of 1000 dimension). 
iii. The computed index is converted to spectrum group number (saved array value). 
iv. The selected spectrum group is tested against its actual CDF and adjusted 
accordingly if it fails the test. 
 
3. Section 3: Phantom-Patient Information  as shown in Figure B-4: 
a. Material map box dimension (e.g., X-Length, Y-Length and Z-Length.) 
b. Length ranges (e.g., Low and high value for each dimension.) 
c. Voxel dimension. 
d. First voxel corner coordinate. 
e. Material Map type: 
i. Homogenous. 
ii. Nonhomogeneous.    
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Figure B-4 Input file view of section 3 data 
 
4. Section 4: Source position and beam blocking (Linac-Specifications and Field 
Parameters) parameters as illustrated in Figure B-5. 
 
 
Figure B-5 Input file view of section4   
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This information is: 
a. Source coordinates. 
b. Isocenter coordinates. 
c. Source Axial Distance. 
d. Source Middle MLC Distance. 
e. Enclosed Limits is at Distance. 
f. Maximum field size at source axial distance (used to compute maximum angle of 
the primary collimator opening. This will affect particle initial weight. 
g. Magnification Factor 
h. Field Type as shown in Figure B-6: 
 
 
Figure B-6 Input file view of section 4 MLC leaf data 
 
The field can be either: 
i. Open. 
ii. Blocked (MLC or Block). If the field blocked we can read the following: 
1. If MLC’s you will have MLC data information (e.g., number of 
limit points, first and last leaf pair followed by listing of the leaf 
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number, minimum, maximum of X and Y jaws and leaf thickness 
given in rows of data. 
2. If block you will have Block data information (e.g., number of 
polygon data points followed by listing of , o coordiantes) 
i. Number of Leaf Pairs. 
j. Number of Plan Beams. 
k. Beam Angle 
l. Jaws Type: 
i. Symmetric. 
ii. Asymmetric. 
m. Jaw limits (list the maximum and minimum for the X and Y jaws.) 
 
This is illustrated in Figure B-7 below: 
 
 
Figure B-7 Input file view of section 4 MLC/blocked field data 
 
5. Section 5: This section contains needed information regarding the materials present in the 
problem.  Figure B-8 illustrate the organization of this section. This information is: 
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a. Number of materials in the problem. 
b. Listing of materials in problem. 
c. Problem material information including: 
i. Elemental composition of each material followed by: 
1. Density. 
2. Z number. 
3. Atomic weight. 
4. Weight fraction 
 
 
Figure B-8 Input file view of section 5 data 
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6. Section 6: For each problem present material the cross sections are listed in rows with 
several columns. The rows represent groups as shown in Figure B-9 and each column is: 
a. Column 1: Group number. 
b. Column 2: Middle group structure energy bin. 
c. Column 3: Absorption probability, 
d. Column 4: Absorption heat cross section. 
e. Column 5: Down scattering probability. 
f. Column 6: Scattering heat cross section 
g. Column 7: Total cross section. 
h. Column 8: Total heat cross section. 
 
Figure B-9 Input file view of section 6 data 
 
The following is how read data read from this section is used: 
i. The first two columns indicate current group number and the mid bin value and 
primarily used for plotting purposes. 
ii. The absorption or scattering probability is used to decide whether the interaction 
is absorption or scattering.  The absorption probability is not being used currently. 
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iii.  The absorption heat is being used for the simulation.  The dose contributed to that 
problem is the value of the absorption heat cross section, if the type of interaction 
is an absorption reaction.  If it was a scattering section, the scattering heat cross 
section would be contributed to dose. 
iv. The total cross section is used to determine the distance to the interaction site. 
v.  The total heat cross section not used in the current program. 
 
7. Section 7: Tabulation of group to group scattering probabilities for each material in the 
problem as shown in Figure B-10.  Each group data is in one row. The number of data 
rows in this table is given. The following is the sequence of data in the each group row: 
a. Initial group. 
b. Final group (down scatter group). 
c. Number of probability points following in this data line. 
d. The current group CDF table entries. The first value represents the maximum 
probability for scattering to the lowest energy group while the last two entries is 
the range of probabilities for scattering to the current group. 
 
 
Figure B-10 Input file view of section 7 data   
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The data in this section is arranged as initial group and the lowest final group.  After that the 
probability is given from the lowest final group to the initial group.  The number of probability 
values varies from 1 all the way to the maximum number based on the lowest final group.  When 
this data is read into the program four two dimensional arrays are created indicating the material 
number and group number. The following is what data arrays are created: 
1. The first array stores the lowest down group. 
2. The second array stores the index of the group probability starting point. 
3. The third array stores the index of the group probability ending point. 
4. The fourth array has a second dimension that is equal to the maximum scatter 
data records. This array stores the down scatter group to group probability. 
8. Section 8: Tabulation of the group to group scattering angles for each material in the 
problem.  Each group data is in one row.  The input deck contains two types of cosine 
scattering data.  The  following is a description of both types: 
a. Type I: Average of cosine scattering angle as described in the Mores code shown 
in Figure B-11.  The number of data rows in this table is given. The following is 
the sequence of data in the each group row. : 
i. Initial group. 
ii. Final group (scatter down to group.) 
iii. Zero Order Legendre coefficient. 
iv. First order Legendre coefficient. 
v. The computed average cosine scattering angle. 
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Figure B-11 Input file view of section 8 data of type I 
 
b. Type II: Tabulates the angular probability distribution function of cosine 
scattering angle shown in Figure B-12. Further; the number of group to group data 
lines in the table, the number of cosine of scattering angle values and its 
corresponding probability per data line is also listed. The following is the 
sequence of data in the each group row: 
c. Initial group. 
d. Final group (scatter down to group.) 
e. A sequence of cosine of scattering angle values followed by the same number of 
the probability distribution value of these cosines scattering angle. 
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Figure B-12 Input file view of section 8 data of type II 
 
The (µ) value and its corresponding probability are tabulated in each line. To store this data 
in a compact way it is read for each problem material into the program using the following 
arrays: 
1. Two dimensional array that stores the starting group for the specified group to 
group scattering.  Index one represents the material number and second index 
represents the particular group to group scattering (data line). 
2. Two dimensional array that stores the final down group for the specified 
group to group scattering.  Index one represents the material number and 
second index represents the particular group to group scattering (data line). 
3. Three dimensional array that store the specified (µ) values. Index one 
represents the material number and second index represents the particular 
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group to group scattering (data line) and index three represent the listed (µ) 
value. 
4. Three dimensional array that store the specified probability for the given (µ) 
values. Index one represents the material number and second index represents 
the particular group to group scattering (data line) and index three represent 
the listed probability value for the listed (µ) value. 
 
B.4. Adjoint Monte Carlo with Fictitious scattering input deck 
The adjoint input deck sections 1, 2, 3 and 5 are identical to the forward input deck.  The rest 
of the sections are similar to the forward input deck with modifications that is suitable for adjoint 
transport.  Method of data generation was described in the previous appendix. Here we will 
describe data organization only.  
1. Section 4:  Adjoint source location.  As illustrated in Figure B-13 the user specifies: 
a. Region of interest name (ROI). 
b. Number of region of interest indices. 
c. List of all voxel indices for the region of interest (i, j, k). These indices will be 
converted to (x, y, z) values using voxel dimension. 
 
 
Figure B-13 Adjoint Input file view of section 4 (ROI) indices 
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2. Section 6: For each problem material cross sections and transport data for each energy 
group are listed as shown in Figure B-14.  The rows represent groups (Figure B - 9) and 
each column is: 
a. Column 1: Group number. 
b. Column 2: Middle group structure energy bin. 
c. Column 3: Absorption probability, 
d. Column 4: Absorption heat cross section. 
e. Column 5: Up scattering probability. 
f. Column 6: up scattering heat cross section 
g. Column 7: Total cross section. 
h. Column 8: Total heat cross section. 
 
 
Figure B-14 Adjoint Input file view of section 6 material cross sections and transport data 
 
In this section the total & absorption cross section is identical to the forward cross sections.  
The scattering cross section and scattering probability is different than the forward input file 
data. These values are generated using the method described in the previous section. 
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3. Section 7: Tabulation of group to group scattering probabilities for each problem material 
as shown in Figure B-15.  Each group data is in one row. The number of data rows in this 
table is given. The following is the sequence of data in the each group row: 
a. Initial group. 
b. Final group (up scatter group). 
c. Number of probability points following in this data line. 
d. The current group CDF table entries.  The first value represents the maximum 
probability for scattering to the current energy group while the last two entries is 
the range of probabilities for scattering to the highest energy group. 
 
 
Figure B-15 Input file view of section 7 data 
 
The data in this section is arranged as initial group and the highest final group.  After that the 
probability is given from the current group to the highest final group.  The number of probability 
values varies from 1 all the way to the maximum number based on the highest final group.  
When this data is read into the program four two dimensional arrays are created indicating the 
material number and group number. The following is what data arrays are created: 
i. The first array stores the current group. 
ii. The second array stores the index of the group probability starting point. 
iii. The third array stores the index of the group probability ending point. 
iv. The fourth array has a second dimension that is equal to the maximum scatter 
data records. This array stores the up scatter group to group probability. 
132 
 
4. Section 8: Tabulation of group to group scattering angles for each material.  Each group 
data is in one row.  The input deck contains two types of cosine scattering data.  The  
following is a description of both types: 
 
a. Type I: Average of cosine scattering angle as described in the Mores code shown 
in Figure B-16.  The number of data rows in this table is given. The following is 
the sequence of data in the each group row. : 
i. Initial group. 
ii. Final group (up scatter group.) 
iii. Zero Order Legendre coefficient. 
iv. First order Legendre coefficient. 
v. The computed average cosine scattering angle. 
 
 
Figure B-16 Input file view of section 8 data of type I 
 
b. Type II: Tabulates the angular probability distribution function of cosine 
scattering angle shown in Figure B-17. Further; the number of group to group data 
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lines in the table, the number of cosine of scattering angle values and its 
corresponding probability per data line is also listed. The following is the 
sequence of data in the each group row: 
i. Initial group. 
ii. Final group (up scatter group.) 
iii. A sequence of cosine of scattering angle values followed by the same 
number of the probability distribution value of these cosines scattering 
angle. 
 
 
Figure B-17 Input file view of section 8 data of type II 
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The (µ) value and its corresponding probability are tabulated in each line. To store this data 
in a compact way it is read for each problem material into the program using the following 
arrays: 
i. Two dimensional array that stores the starting group for the specified group to 
group scattering.  Index one represents the material number and second index 
represents the particular group to group scattering (data line). 
ii. Two dimensional array that stores the final up group for the specified group to 
group scattering.  Index one represents the material number and second index 
represents the particular group to group scattering (data line). 
iii. Three dimensional array that store the specified (µ) values. Index one 
represents the material number and second index represents the particular 
group to group scattering (data line) and index three represent the listed (µ) 
value. 
iv. Three dimensional array that store the specified probability for the given (µ) 
values. Index one represents the material number and second index represents 
the particular group to group scattering (data line) and index three represent 
the listed probability value for the listed (µ) value. 
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Appendix C 
Forward continuous and multigroup MCNP5 input deck  
The following are the MCNP5 input decks used to estimate (Voxel) fluxes using MCNP5 
FMESH4 tally and the deck that estimates the average dose rates in the problem regions of 
interest: the tumor, the brain, and both eyes.  The calculations use the built-in 12 group photon 
cross sections, which are also used in the Pixel8 and Voxel8 calculations. 
C.1. MCNP5 multigroup input deck to get flux map 
 
Forward MC CAX PDD Sim - Varian 6 MV Spectrum-MCNP-MGXSNP Grp Strctre 
c ******************************************************************* 
c      Cells  - 50.0 x 50.0 x 50.0 Water Box                          
c ******************************************************************* 
  1   1 -1 -1           imp:p=1   $ 50.0x50.0x50.0 Water box          
  2   0 -2 3            imp:p=0   $ thin layer surrounding window     
  3   0 -3              imp:p=1   $ 10 x 10 window                    
  4   0 #1 #2 #3 -100   imp:p=1   $ outside water box inside universe 
  5   0 +100            imp:p=0   $ Outside universe -void            
 
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
  100 so  200.0                            $ Universe bound           
  1   RPP -25.0 25.0 0.0 50.0 -25.0 25.0   $ Water box 50.0x50.0x50.0 
  2   RPP -25.0 25.0 -0.001 0.0 -25.0 25.0 $ thin Field Plate         
  3   RPP -5.0 5.0 -0.001 0.0 -5.0 5.0     $ Field size 10.0 x 10.0   
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c                                                                     
c Photon point source positioned at (0.0,-100.0,0.0) all particles    
c travelling in direction <0.0,-1.0,0.0>. Source energy distribution  
c is according to the published 2100-6MV spectrum. Direction is       
c limited to a 40.0 cm diameter circle at 100.0 cm from the source.   
c max angle is Acos(100/101.98=0.980581) = 11.30993-                  
c mu from 1.0 --> 0.980581. to normalize to the particles in the cone 
c use WGT=1/fsa2 (fsa2= fraction solid angle of the cone)             
c This is a 40.0 cm circle run                                        
SDEF POS 0.0 -100.0 0.0 VEC 0.0 1.0 0.0                               
     ERG d1 DIR d2 PAR 2                                              
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c 
SI1 H 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000 
SP1 D 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534 
      0.093532  0.048771  0.011591 
c                                                                     
c ******************************************************************* 
c         Picking in a 11.30993 cone (Bias = 1/ 0.0097097)            
c ******************************************************************* 
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c                                                                     
SI2 -1.0 0.9805807 1.0         $ Histogram for cosine bin limits      
SP2 0.0  0.9902903 0.0097097   $ frac. solid angle for each bin       
SB2 0.  0.  1.                 $ source bias for each bin             
c                                                                     
c *************** Materials ***************************************** 
c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
 M1   1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
c ******************** Problem FMESH4 Tally ************************* 
c ******************************************************************* 
c                                                                     
FC4 Multi-group Varian 6 MV Spectrum-MCNP-MGXSNP Grp Strctre          
FMESH4:P GEOM=xyz                                                     
          ORIGIN=-25 0 0                                              
          IMESH=25.   IINTS=100                                       
          JMESH=50.    JINTS=100                                      
          KMESH=.5   KINTS=1                                          
          OUT=ij                                                      
          EMESH = 6.000                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY Dose Conversion factors     **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c 
 E0  0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000 
 EM0 3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09  7.76637E-09 
     9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c 
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c EMCPF = Upper energy limit for detailed photon physics treatment,   
c         in MeV.                                                     
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 0.01                                                          
MODE P                                                                
PHYS:P 6.000 1                                                        
MGOPT F 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 250000000                                                         
PRINT   
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C.2. Forward model for structure doses 
Forward Eyes Tumor Brain - Varian 6MV Spectrum-MCNP-MGXSNP Grp Strctr 
c ******************************************************************* 
c  Cells  - 50.0 x 50.0 x 50.0 Water Box with 3 structures            
c ******************************************************************* 
 1     1 -1.0 -1              imp:p=1 $ Tumor                         
 2     1 -1.0 -2              imp:p=1 $ Right eye                     
 3     1 -1.0 -3              imp:p=1 $ Left eye                      
 4     1 -1.0 -4:-5:-6        imp:p=1 $ Brain                         
 5     1 -1.0 -7 #1 #2 #3 #4  imp:p=1 $ 50.0x50.0x50.0 Water box      
 6     0 -8 9                 imp:p=0 $ thin layer above box          
 7     0 -9                   imp:p=1 $ 20 x 20 window                
 8     0 #1 #5 #6 #7 -100     imp:p=1 $ outside water box in universe 
 9     0 +100                 imp:p=0 $ Outside universe - void       
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
 1     S  4.5 15.0 3.0 1.5                  $ Tumor                   
 2     S  -7.0 4.0 0.0 3.5                  $ Right Eye               
 3     S   7.0 4.0 0.0 3.5                  $ Left Eye                
 4     RPP -10.0 10.0 17.0 29.5 -9.0   1.0  $ Brain - Box 1           
 5     RPP -10.0 10.0 21.0 28.5   1.0  8.0  $ Brain - Box 2           
 6     RPP -10.0 10.0  3.5 31.0   8.0 15.0  $ Brain - Box 3           
 7     RPP -25.0 25.0 0.0 50.0 -25.0 25.0   $ Water box 50.0x50.0x50. 
 8     RPP -25.0 25.0 -0.001 0.0 -25.0 25.0 $ thin Field Plate        
 9     RPP -5.0 5.0 -0.001 0.0 -5.0 5.0     $ Field size 10.0 x 10.0  
 100   so  200.0                            $ Universe bound          
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c                                                                     
c Photon point source positioned at (0.0,-100.0,0.0) all particles    
c travelling in direction <0.0,-1.0,0.0>. Source energy distribution  
c is according to the published 2100-6MV spectrum. Direction is       
c limited to a 40.0 cm diameter circle at 100.0 cm from the source.   
c max angle is Acos(100/101.98=0.980581) = 11.30993-                  
c mu from 1.0 --> 0.980581. to normalize to the particles in the cone 
c use WGT=1/fsa2 (fsa2= fraction solid angle of the cone)             
c This is a 40.0 cm circle run                                        
SDEF  POS 0.0 -100.0 0.0 VEC 0.0 1.0 0.0                              
      ERG d1 DIR d2 PAR 2 WGT 1.03018e2                               
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c 
SI1 H 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000 
SP1 D 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534 
      0.093532  0.048771  0.011591 
c                                                                     
c ******************************************************************* 
c                 Picking in a 11.30993 cone (Bias = 1/ 0.009707)     
c ******************************************************************* 
c                                                                     
SI2 -1 0.980581 1.            $ Histogram for cosine bin limits       
SP2 0.0 0.99029 0.009707      $ frac. solid angle for each bin        
SB2 0.  0.  1.                $ source bias for each bin              
c                                                                     
c *************** Materials ***************************************** 
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c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
M1    1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
c ******************** Problem FMESH4 Tally ************************* 
c ******************************************************************* 
c                                                                     
FC4 Tumor Absorbed dose (cGy)                                         
F4:P 1                                                                
FC14 Right Eye Absorbed dose (cGy)                                    
F14:P 2                                                               
FC24 Left Eye Absorbed dose (cGy)                                     
F24:P 3                                                               
FC34 Brain Absorbed dose (cGy)                                        
F34:P 4                                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY99 Dose Conversion factors   **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c 
E0    0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000   
EM0   3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09  7.76637E-09 
      9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c 
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c EMCPF = Upper energy limit for detailed photon physics treatment,   
c         in MeV.                                                     
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 0.001                                                         
MODE P                                                                
PHYS:P 6.000 1                                                        
MGOPT F 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 100000000                                                         
PRINT    
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Appendix D 
Adjoint MCNP5 surface cell fluxes input decks 
 
The following are the MCNP5 input decks used to run MCNP5 in adjoint mode to compute 
cell fluxes using FMESH4 tally.  The calculation was repeated for multiple region of interest 
(adjoint sources).  The adjoint source distribution was derived from the region of interest 
response function. 
D.1. Adjoint model simple Box 
 
Adjoint with MCNP-MGXSNP - Adjoint Source as a box (1.50x1.50x1.50)   
c ******************************************************************* 
c      Cells  - 50.0 x 50.0 x 50.0 Water Box                          
c ******************************************************************* 
  1   1 -1.0  -1        imp:p=1   $ Adjoint source box                
  2   1 -1.0  -2 #1     imp:p=1   $ 50.0x50.0x50.0 Water box          
  3   0 #2  -100        imp:p=0   $ outside water box inside universe 
  4   0 +100            imp:p=0   $ Outside universe -void            
 
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
c                                                                     
  1   RPP -0.5 1.0 5.0 6.5 -0.5 1.0        $ Adjoint Source           
  2   RPP -25.0 25.0 0.0 50.0 -25.0 25.0   $ Water box 50.0x50.0x50.0 
  3   PY   0                               $ Crossing plane           
  100 so  200.0                            $ Universe bound           
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c Adjoint source is in cell number 1. The cell is made out of         
c parallelepiped with given dimensions. Points are chosen uniformly   
c  within the parallelepiped.                                         
c                                                                     
SDEF  PAR=2  ERG=d1  X=d2  Y=d3  Z=d4  CEL=1                          
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c                                                                     
SI1 H 0.000 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000    
      6.000                                                           
SP1 D 0.000000000  3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09 
      7.76637E-09  9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c                                                                     
c ******************************************************************* 
c *************** Where to pick starting points ********************* 
c ******************************************************************* 
SI2 -0.5 1.0                 $ X-range for Adjoint source             
SP2  0.0 1.0                 $ uniform probability over the X-range   
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SI3  5.0 6.5                 $ Y-range for Adjoint source             
SP3  0.0 1.0                 $ uniform probability over the Y-range   
SI4 -0.5 1.0                 $ Z-range for Adjoint source             
SP4  0.0 1.0                 $ uniform probability over the Z-range   
c 
c ******************************************************************* 
c *************** Materials ***************************************** 
c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
 M1   1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
c ********************  Problem FMESH4 Tally  *********************** 
c ********************   Need to have EMESH   *********************** 
c ******************** to run Adjoint problem *********************** 
c ******************************************************************* 
c                                                                     
FC4 Adjoint with MCNP-MGXSNP - Adjoint Source a box (1.50x1.50x1.50)  
FMESH4:P GEOM=xyz                                                     
          ORIGIN=-25 0 -25                                            
          IMESH=25.   IINTS=100                                       
          JMESH=.5    JINTS=1                                         
          KMESH=25.   KINTS=100                                       
          OUT=ik                                                      
          EMESH = 6.000                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY Dose Conversion factors     **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c                                                                     
 E0  0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000    
 EM0 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534       
     0.093532  0.048771  0.011591                                     
c                                                                     
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 6.000                                                         
MODE P                                                                
c SSW -3                                                              
MGOPT A 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 250000000                                                         
PRINT    
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D.2. Adjoint model of tumor (Sphere) 
 
Adjoint-MCNP-MGXSNP - Adjoint Source Tumor(4.5,15.0,3.0) R=1.5 cm     
c ******************************************************************* 
c      Cells  - 50.0 x 50.0 x 50.0 Water Box                          
c ******************************************************************* 
  1   1 -1.0  -1 -2     imp:p=1   $ Adjoint source Tumor              
  2   1 -1.0  -2 #1     imp:p=1   $ 50.0x50.0x50.0 Water box          
  3   0 #2  -100        imp:p=0   $ outside water box inside universe 
  4   0 +100            imp:p=0   $ Outside universe -void            
 
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
c                                                                     
  1   S  4.5 15.0 3.0 1.5                  $ Adjoint Source Tumor     
  2   RPP -25.0 25.0 0.0 50.0 -25.0 25.0   $ Water box 50.0x50.0x50.0 
  3   PY   0                               $ Crossing plane           
  100 so  200.0                            $ Universe bound           
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c Adjoint source is in cell number 1. The cell is made out of         
c parallelepiped with given dimensions. Points are chosen uniformly   
c  within the parallelepiped.                                         
c                                                                     
SDEF  PAR=2  ERG=d1  X=d2  Y=d3  Z=d4  CEL=1                          
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c                                                                     
SI1 H 0.000 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000    
      6.000                                                           
SP1 D 0.000000000  3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09 
      7.76637E-09  9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c                                                                     
c ******************************************************************* 
c *************** Where to pick starting points ********************* 
c ******************************************************************* 
SI2   2.5  6.5               $ X-range for Adjoint source             
SP2   0.0  1.0               $ uniform probability over the X-range   
SI3  13.0 17.0               $ Y-range for Adjoint source             
SP3   0.0  1.0               $ uniform probability over the Y-range   
SI4   1.0  5.0               $ Z-range for Adjoint source             
SP4   0.0  1.0               $ uniform probability over the Z-range   
c 
c ******************************************************************* 
c *************** Materials ***************************************** 
c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
 M1   1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
c ********************  Problem FMESH4 Tally  *********************** 
c ********************   Need to have EMESH   *********************** 
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c ******************** to run Adjoint problem *********************** 
c ******************************************************************* 
c                                                                     
FMESH4:P GEOM=xyz                                                     
          ORIGIN=-25 0 -25                                            
          IMESH=25.   IINTS=100                                       
          JMESH=.5    JINTS=1                                         
          KMESH=25.   KINTS=100                                       
          OUT=ik                                                      
          EMESH = 6.000                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY99 Dose Conversion factors   **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c                                                                     
 E0  0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000    
 EM0 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534       
     0.093532  0.048771  0.011591                                     
c                                                                     
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 6.000                                                         
MODE P                                                                
c SSW -3                                                              
MGOPT A 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 1000000                                                           
PRINT     
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D.3. Adjoint model of right eye (Sphere) 
 
Adjoint-MCNP-MGXSNP - Adjoint Source RtEye(-7.0,4.0,0.0) R=3.5 cm     
c ******************************************************************* 
c      Cells  - 50.0 x 50.0 x 50.0 Water Box                          
c ******************************************************************* 
  1   1 -1.0  -1 -2     imp:p=1   $ Adjoint source  Rt Eye            
  2   1 -1.0  -2 #1     imp:p=1   $ 50.0x50.0x50.0 Water box          
  3   0 #2  -100        imp:p=0   $ outside water box inside universe 
  4   0 +100            imp:p=0   $ Outside universe -void            
 
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
c                                                                     
  1   S  -7.0 4.0 0.0 3.5                  $ Adjoint Source Rt Eye    
  2   RPP -25.0 25.0 0.0 50.0 -25.0 25.0   $ Water box 50.0x50.0x50.0 
  3   PY   0                               $ Crossing plane           
  100 so  200.0                            $ Universe bound           
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c Adjoint source is in cell number 1. The cell is made out of         
c parallelepiped with given dimensions. Points are chosen uniformly   
c  within the parallelepiped.                                         
c                                                                     
SDEF  PAR=2  ERG=d1  X=d2  Y=d3  Z=d4  CEL=1                          
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c                                                                     
SI1 H 0.000 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000    
      6.000                                                           
SP1 D 0.000000000  3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09 
      7.76637E-09  9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c                                                                     
c ******************************************************************* 
c *************** Where to pick starting points ********************* 
c ******************************************************************* 
SI2 -11.0 -2.0               $ X-range for Adjoint source             
SP2   0.0  1.0               $ uniform probability over the X-range   
SI3   0.1  8.0               $ Y-range for Adjoint source             
SP3   0.0  1.0               $ uniform probability over the Y-range   
SI4  -4.0  4.0               $ Z-range for Adjoint source             
SP4   0.0  1.0               $ uniform probability over the Z-range   
c 
c ******************************************************************* 
c *************** Materials ***************************************** 
c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
 M1   1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
c ********************  Problem FMESH4 Tally  *********************** 
c ********************   Need to have EMESH   *********************** 
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c ******************** to run Adjoint problem *********************** 
c ******************************************************************* 
c                                                                     
FC4 Adjoint-MCNP-MGXSNP - Adjoint Source RtEye(-7.0,4.0,0.0) R=3.5 cm 
FMESH4:P GEOM=xyz                                                     
          ORIGIN=-25 0 -25                                            
          IMESH=25.   IINTS=100                                       
          JMESH=.5    JINTS=1                                         
          KMESH=25.   KINTS=100                                       
          OUT=ik                                                      
          EMESH = 6.000                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY Dose Conversion factors     **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c                                                                     
 E0  0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000    
 EM0 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534       
     0.093532  0.048771  0.011591                                     
c                                                                     
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 6.000                                                         
MODE P                                                                
c SSW -3                                                              
MGOPT A 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 250000000                                                         
PRINT                                                                 
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D.4. Adjoint model for left eye (Sphere) 
 
Adjoint-MCNP-MGXSNP - Adjoint Source LtEye(7.0,4.0,0.0) R=3.5 cm      
c ******************************************************************* 
c      Cells  - 50.0 x 50.0 x 50.0 Water Box                          
c ******************************************************************* 
  1   1 -1.0  -1 -2     imp:p=1   $ Adjoint source  Lt Eye            
  2   1 -1.0  -2 #1     imp:p=1   $ 50.0x50.0x50.0 Water box          
  3   0 #2  -100        imp:p=0   $ outside water box inside universe 
  4   0 +100            imp:p=0   $ Outside universe -void            
 
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
c                                                                     
  1   S   7.0 4.0 0.0 3.5                  $ Adjoint Source Lt Eye    
  2   RPP -25.0 25.0 0.0 50.0 -25.0 25.0   $ Water box 50.0x50.0x50.0 
  3   PY   0                               $ Crossing plane           
  100 so  200.0                            $ Universe bound           
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c Adjoint source is in cell number 1. The cell is made out of         
c parallelepiped with given dimensions. Points are chosen uniformly   
c  within the parallelepiped.                                         
c                                                                     
SDEF  PAR=2  ERG=d1  X=d2  Y=d3  Z=d4  CEL=1                          
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c                                                                     
SI1 H 0.000 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000    
      6.000                                                           
SP1 D 0.000000000  3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09 
      7.76637E-09  9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c                                                                     
c ******************************************************************* 
c *************** Where to pick starting points ********************* 
c ******************************************************************* 
SI2   3.0  11.0              $ X-range for Adjoint source             
SP2   0.0   1.0              $ uniform probability over the X-range   
SI3   0.1   8.0              $ Y-range for Adjoint source             
SP3   0.0   1.0              $ uniform probability over the Y-range   
SI4  -4.0   4.0              $ Z-range for Adjoint source             
SP4   0.0   1.0              $ uniform probability over the Z-range   
c 
c ******************************************************************* 
c *************** Materials ***************************************** 
c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
 M1   1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
c ********************  Problem FMESH4 Tally  *********************** 
c ********************   Need to have EMESH   *********************** 
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c ******************** to run Adjoint problem *********************** 
c ******************************************************************* 
c                                                                     
FC4 Adjoint-MCNP-MGXSNP - Adjoint Source LtEye(7.0,4.0,0.0) R=3.5 cm  
FMESH4:P GEOM=xyz                                                     
          ORIGIN=-25 0 -25                                            
          IMESH=25.   IINTS=100                                       
          JMESH=.5    JINTS=1                                         
          KMESH=25.   KINTS=100                                       
          OUT=ik                                                      
          EMESH = 6.000                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY Dose Conversion factors     **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c                                                                     
 E0  0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000    
 EM0 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534       
     0.093532  0.048771  0.011591                                     
c                                                                     
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 6.000                                                         
MODE P                                                                
c SSW -3                                                              
MGOPT A 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 250000000                                                         
PRINT                                                                 
  
147 
 
D.5. Adjoint model for brain (made out of three boxes) 
 
Adjoint-MCNP-MGXSNP - Adjoint Source Brain - made of three boxes      
c ******************************************************************* 
c      Cells  - 50.0 x 50.0 x 50.0 Water Box                          
c ******************************************************************* 
  1   1 -1.0 (-1:-4:-5) -2 imp:p=1   $ Adjoint source  Lt Eye         
  2   1 -1.0  -2 #1        imp:p=1   $ 50.0x50.0x50.0 Water box       
  3   0 #2  -100           imp:p=0   $ outside box inside universe    
  4   0 +100               imp:p=0   $ Outside universe -void         
 
c ******************************************************************* 
c      Surfaces                                                       
c ******************************************************************* 
c                                                                     
  1   RPP -10.0 10.0 17.0 29.5 -9.0   1.0  $ Adjoint Source - Box 1   
  2   RPP -25.0 25.0  0.0 50.0 -25.0 25.0  $ Water box 50.0x50.0x50.0 
  3   PY   0                               $ Crossing plane           
  4   RPP -10.0 10.0 21.0 28.5   1.0  8.0  $ Adjoint Source - Box 2   
  5   RPP -10.0 10.0  3.5 31.0   8.0 15.0  $ Adjoint Source - Box 3   
  100 so  200.0                            $ Universe bound           
 
c ******************************************************************* 
c      Data Cards                                                     
c ******************************************************************* 
c Adjoint source is in cell number 1. The cell is made out of         
c parallelepiped with given dimensions. Points are chosen uniformly   
c  within the parallelepiped.                                         
c                                                                     
SDEF  PAR=2  ERG=d1  X=d2  Y=d3  Z=d4  CEL=1                          
c                                                                     
c ******************************************************************* 
c ************  Energy Distribution 2100-6MV  *********************** 
c ************  Group structure MCNP-MGXSNP   *********************** 
c ******************************************************************* 
c                                                                     
SI1 H 0.000 0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000    
      6.000                                                           
SP1 D 0.000000000  3.12689E-10  9.90001E-10  3.00098E-09  5.29621E-09 
      7.76637E-09  9.74813E-09  1.15586E-08  1.33190E-08  1.49516E-08 
c                                                                     
c ******************************************************************* 
c *************** Where to pick starting points ********************* 
c ******************************************************************* 
SI2 -10.0 10.0               $ X-range for Adjoint source             
SP2   0.0  1.0               $ uniform probability over the X-range   
SI3   3.5 31.0               $ Y-range for Adjoint source             
SP3   0.0  1.0               $ uniform probability over the Y-range   
SI4  -9.0 15.0               $ Z-range for Adjoint source             
SP4   0.0  1.0               $ uniform probability over the Z-range   
c 
c ******************************************************************* 
c *************** Materials ***************************************** 
c ******************************************************************* 
c WATER for gamma-ray transport (by mass fraction)                    
c ******************************************************************* 
c                                                                     
 M1   1000 -0.11190               $ elemental H mass fraction         
      8000 -0.88810               $ elemental O mass fraction         
c                                                                     
c ******************************************************************* 
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c ********************  Problem FMESH4 Tally  *********************** 
c ********************   Need to have EMESH   *********************** 
c ******************** to run Adjoint problem *********************** 
c ******************************************************************* 
c                                                                     
FC4 Adjoint-MCNP-MGXSNP - Adjoint Source Brain - made of three boxes  
FMESH4:P GEOM=xyz                                                     
          ORIGIN=-25 0 -25                                            
          IMESH=25.   IINTS=100                                       
          JMESH=.5    JINTS=1                                         
          KMESH=25.   KINTS=100                                       
          OUT=ik                                                      
          EMESH = 6.000                                               
c                                                                     
c ******************************************************************* 
c ****************  NJOY Dose Conversion factors     **************** 
c ****************  For MCNP-MGXSNP group structure  **************** 
c ******************************************************************* 
c                                                                     
 E0  0.010  0.100  0.500  1.000  2.000  3.000  4.000  5.000  6.000    
 EM0 0.000000  0.007698  0.133707  0.235028  0.303138  0.166534       
     0.093532  0.048771  0.011591                                     
c                                                                     
c ******************************************************************* 
c PHYS:P EMCPF IDES NOCOH ISPN NODOP                                  
c To turn off electron production and the bremsstrahlung photons      
c use IDES=1 default =0 --> thick target bremsstrahlung. To turn      
c off coherent scattering NOCOH=1; photo nuclear collision ISPN=0     
c Doppler energy broadening NODOP=1                                   
c ******************************************************************* 
c                                                                     
CUT:P J 6.000                                                         
MODE P                                                                
c SSW -3                                                              
MGOPT A 12                                                            
c PRINT 100 40 110 150 160 161 162                                    
NPS 250000000                                                         
PRINT                                                                 
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